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The obligate human pathogen Neisseria gonorrhoeae successfully overcomes 
host strategies to limit essential nutrients, termed “nutritional immunity” by expression of 
TonB-dependent transporters (TdTs): outer membrane receptors that facilitate nutrient 
transport in an energy-dependent manner. N. gonorrhoeae encodes eight TdTs, five of 
which facilitate utilization of iron or iron-chelates from host derived proteins including 
transferrin, lactoferrin and hemoglobin, in addition to siderophores from neighboring 
bacteria. The transferrin utilization system was previously shown to be critical for 
establishing infection in human males; demonstrating the possible contributions of TdTs 
 xvii 
 
to gonococcal pathogenesis. As such, studies describing the biological function and 
contribution to pathogenesis of the remaining three uncharacterized TdTs (TdfG, TdfH 
and TdfJ) are needed. In this study we report that neither TdfG, TdfH nor TdfJ are heme 
receptors as gonococcal heme utilization occurs passively, independent of energy 
derived from the TonB system. We also report that TdfH and TdfJ are zinc (Zn) 
regulated and identify virulence associated regulators that modulate expression of these 
TdTs, which is in some cases strain-specific. We report that both TdfH and TdfJ 
contribute to Zn acquisition in N. gonorrhoeae and we characterize TdfH as a 
calprotectin receptor. Calprotectin, an immune effector protein highly expressed in 
neutrophils, has antimicrobial activity due to its ability to sequester Zn and Mn. We 
present evidence that TdfH confers resistance to calprotectin and that TdfH facilitates 
gonococcal calprotectin binding and Zn accumulation in the presence or absence of 
calprotectin. Finally, we demonstrate that TdfH expression enhances N. gonorrhoeae 
NET survival. These studies identify for the first time a novel gonococcal defense 
strategy to host-mediated nutritional immunity, in which N. gonorrhoeae, via the TdT 
TdfH, utilizes calprotectin as a Zn source neutralizing its antimicrobial activity. These 
studies have yielded novel insights into the function and regulation of TdfG, TdfH and 
TdfJ in N. gonorrhoeae and have laid the framework for future investigation of TdT-
mediated Zn acquisition and its role in bacterial pathogenesis.   
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Chapter 1: Introduction 
 
 
 
I. Neisseria 
The genus Neisseria belongs to the family Neisseriaceae, which is also 
comprised of 3 other genera: Moraxella, Acinetobacter and Kingella [121]. Members of 
the Neisseriaceae family can be differentiated from one another by cell morphology and 
biochemical properties such as the ability to produce acid from glucose and reduce 
nitrate as well as the presence of oxidase, catalase, carbonic anhydrase and thymidine 
kinase [25]. The Neisseria genus is comprised of a number of species which can occur 
as normal flora or pathogens in humans. The Neisseria species are non-motile, Gram-
negative diplococci with flattened adjacent sides that are aerobic or facultatively 
anaerobic and grow optimally at temperatures between 35-37°C [25]. Human 
associated Neisseria spp. can be identified by their acid production from carbohydrates, 
their ability to reduce nitrite and produce polysaccharide from sucrose [121].   
 
II. Pathogenic Neisseria species 
The only Neisseria species that is always considered pathogenic is Neisseria 
gonorrhoeae. It infects the mucosal surfaces of urogenital sites and the oro-
nasopharynx, causing symptomatic or asymptomatic infections. In some cases, 
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Neisseria meningitidis can be pathogenic causing sporadic cases or epidemics of 
meningitis. Strains of N. meningitidis can be carried as normal flora in the nasopharynx 
of healthy individuals. Most Neisseria species are commensal and colonize the 
oropharynx without causing disease. Some commensal species have been sporadically 
isolated from disseminated sites, blood, and cerebrospinal fluid, although they are not 
normally associated with invasive infections. Commensal species appear to be 
opportunistic pathogens, causing infection in people with deficient immune systems 
[121]. 
 
III. Meningococcal disease 
A. Epidemiology 
Neisseria meningitidis colonizes the nasopharynx where it exists as a 
commensal bacterium. Though carriage rates can vary among human populations, as 
many as 10% of adolescents and adults are asymptomatic carriers [37].Transmission of 
N. meningitidis can occur directly via person-to-person contact or through respiratory 
droplets from an infected to a susceptible individual. As such, transmission and carriage 
rates increase dramatically in closed settings such as residential schools and military 
camps [37]. Carriage can last as long as months and is least prevalent in the early 
years of life and most prevalent in young adults [218]. Persons with immune 
deficiencies such as deficiencies in terminal complement components have increased 
susceptibility to meningococcal disease as well as people with exposure to tobacco 
smoke and concurrent viral infection of the upper respiratory tract [199]. 
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Despite high carriage rates, meningococcal disease is rare, occurring at annual 
incidence rates of 1-1000 per 100,000 population throughout the world [37]. N. 
meningitidis strains can be separated into thirteen different serogroups on the basis of 
the polysaccharide capsule, of which six (A, B, C, W135, X and Y) are responsible for 
the majority of invasive meningococcal disease [218]. The highest incidence of 
meningococcal disease occurs in sub-Saharan Africa in the ‘meningitis belt’ where 
incidence can approach up to 1000 cases per 100,000 population during epidemics 
[89]. Serogroup A is most important in this region, though Serogroups C and X can also 
cause disease [89]. In the Americas, Serogroups B, C, and Y are predominant 
meningococcal disease causing strains and result in historically low incidence of 
diseases at 0.3-4 cases per 100,000. Serogroups B and C predominate in Europe, 
Australia, and New Zealand where incidence varies between countries from 0.2-14 
cases per 100,000. In Asia, the burden of meningococcal disease is less well defined, 
though serogroups A and C are thought to be responsible for the infrequent outbreaks 
and low levels of endemic disease in the region [89]. 
B. Infection 
In less than 1% of colonized individuals, meningococci penetrate the mucosal 
epithelia and enter the bloodstream to cause meningococcemia [41]. In half of the cases 
of meningococcal septicemia, the bacteria penetrate the blood brain barrier causing 
meningitis, the most common presentation of invasive meningococcal disease, which 
presents clinically as sudden onset of headache, fever, and neck stiffness and is 
sometimes accompanied by nausea, vomiting, sensitivity to light and altered mental 
status [199]. Meningococcemia or bloodstream infection is characterized by sudden 
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fever and rash and is often associated with hypotension and multi-organ failure [199]. 
The overall case fatality rate of invasive meningococcal disease is 9 -12%, with a rate of 
up to 40% among patients with meningococcal sepsis [199]. A significant number of 
meningococcal survivors have sequelae such as hearing loss, neurologic disability, or 
loss of a limb [199].  
C. Treatment 
N. meningitidis remains susceptible to many antibiotics including penicillin [199]. 
In the US, where few penicillin resistant strains have been reported, penicillin remains 
the first line of therapy recommended after N. meningitidis infections has been 
confirmed [41]. To prevent secondary infection of individuals with close contact to 
patients with meningococcal disease, prophylactic treatment of household members is 
often used as a method of control [199].  
Several meningococcal vaccines are licensed for use in the US. MPSV4, the first 
meningococcal polysaccharide vaccine was approved in 1974. The current 
polysaccharide vaccine (Menomune; Sanofi Pasteur) confers protection against 
Serogroups A, C, Y and W-135 [32]. However, it is poorly immunogenic in infants, 
doesn’t confer long lasting immunity and does not reduce nasopharyngeal carriage of N. 
meningitidis to elicit herd immunity [153]. As such it is only recommended in individuals 
older than 55 years of age when other conjugate vaccines are not available [41]. Three 
meningococcal conjugate vaccines are licensed in the US: two single component 
vaccines—Menactra also known as MCV4 (Sanofi Pasteur) and Menevo (Novartis) and 
a two-component vaccine MenHibrix (GlaxoSmithKline). MCV4 was approved in 2005 
and has meningococcal A, C, W and Y polysaccharides conjugated to diphtheria toxoid 
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protein carrier and is approved for use in persons from 9 months to 55 years of age 
[153]. Menevo, licensed for use in 2010 in persons 2-55 years of age, contains the 
meningococcal A, C, W and Y polysaccharides conjugated to CRM197 (MenA). 
MenHibrix, was licensed for use in 2012 and contains N. meningitidis serogroups C 
capsular polysaccharide conjugated to tetanus toxoid, N. meningitidis serogroup Y 
capsular polysaccharide conjugated to tetanus toxoid and Haemophilus influenzae 
serogroup B capsular polysaccharide conjugated to tetanus toxoid. It is recommended 
as a 4 dose series in children between 2-18 months of age [41].  
Until recently, there was no N. meningitidis serogroup B vaccine licensed for use 
in the US, which causes 50% of invasive disease worldwide and 30% in the US [32]. 
Vaccine development strategies were hindered due to the fact that the polysaccharide 
of N. meningitidis serogroup B contains polysialic structures identical to those 
expressed in fetal neural tissue, and does not induce a protective IgG response [217]. 
As such, novel vaccine development strategies have focused on non-capsular antigens 
[32, 199, 218]. Bexsero® also known as 4CMenB (Novartis), licensed for use in Europe 
and Australia in 2013 and in the US in 2015, is the first broad-spectrum vaccine for N. 
meningitidis serogroup B [130]. 4CMenB is comprised of 4 components against 
meningococcal serogroup B: factor H binding protein (fHbp) fused to accessory protein 
GNA 2091, Neisseria heparin binding antigen (NHba) fused to GNA 1030 and Neisseria 
adhesin A (NadA) all added to an outer membrane vesicle from the serogroup B New 
Zealand strain (strain NZ98/254) [130]. A second group B vaccine, Trumemba® (Pfizer), 
which is composed of two fHbp variants (A05 and B01), was licensed for use in 2014 
[130]. Despite the leaps on the development of vaccine strategies, comprehensive post-
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implementation surveillance plans will be required to monitor the inevitable loss of 
immunity and the potential harmful effects of vaccination.  
 
IV. Gonococcal disease 
A. Epidemiology 
Neisseria gonorrhoeae is the etiological agent of the sexually transmitted 
infection, gonorrhea. Gonorrhea is a significant global health concern causing an 
estimated 106 million new cases each year [267]. In the US, gonorrhea is the second 
most commonly reported communicable disease with 820,000 estimated new cases 
each year, less than half of which are detected and/or reported to the CDC. The key risk 
factor for infection is new or multiple sex partners. In the US, incidence rates are 
generally highest among adolescents and young adults, women and African Americans, 
for whom the rate of reported cases was 12.4 times greater than that of whites [40]. For 
the first time since 2003 the number of reported cases in men was greater than in 
women in 2013 [40].    
B. Infection 
Neisseria gonorrhoeae is transmitted via close sexual contact of infected 
individuals. It can be transmitted perinatally from mother to child during child birth. Thus, 
newborn infants are treated with an ocular prophylactic agent (erythromycin) to prevent 
gonococcal opthalmia [266]. Neisseria gonorrhoeae causes infection in the urogenital, 
anorectal or pharyngeal mucosa. In men, infection is asymptomatic in a minority of 
cases. When present, symptoms occur within 14 days of infection and present as 
dysuria and purulent urethral discharge. Most women are asymptomatic. Symptoms 
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such as dysuria, increased vaginal discharge and vaginal bleeding can sometimes 
present but are non-specific and often mistaken for a bladder or vaginal infection [159]. 
Rectal infection in both men and women can present as soreness, itchiness, discharge 
and bleeding but can also be asymptomatic [120]. Most pharyngeal infection is 
asymptomatic but can also cause sore throat [264].  
Untreated infection can lead to complications and severe morbidity is associated 
with downstream sequelae. In women, gonococcal infection can ascend to the upper 
reproductive tract to cause Pelvic Inflammatory Disease (PID), which can increase the 
risk of ectopic pregnancy and infertility. In men, complicated infection can lead to 
epidymitis, which can rarely lead to infertility. Though rare, N. gonorrhoeae can also 
enter the blood and cause Disseminated Gonococcal Infection (DGI), characterized by 
arthritis, tenosynovitis and dermatitis [99, 196].Gonococcal infection is often associated 
with other infections including Chlamydia trachomatis and can increase the risk of 
acquiring other STI infection and the transmission of HIV [108].         
C. Treatment 
Antimicrobials have been successfully used to treat gonococcal infection for the 
last 70-80 years [242]. However, the ability to treat gonococcal infection has become 
increasingly difficult due to the development of antibiotic resistance. In the 1990-2000 
decade, fluoroquinolone resistance spread throughout the US. As such, in 2007 the 
CDC no longer recommended fluoroquinolones for treatment of uncomplicated 
gonorrhea leaving 3rd generation cephalosporins as the last line of defense to treat 
gonococcal infection [38]. In 2010 the STD Treatment Guidelines recommended dual 
therapy with a cephalosporin—Cefixime (oral) or Ceftriaxone (intramuscular) plus 
 8 
 
azithromycin or doxycycline for the treatment of co-occurring pathogen Chlamydia 
trachomatis. However, treatment failures with cefixime and ceftriaxone and declining 
cefixime susceptibility to collected urethral isolates reported by the CDCs Gonococcal 
Surveillance Isolate Project (GISP) led to a 2012 revision, which now only recommends 
ceftriaxone plus azithromycin or doxycycline as the only reliable treatment of 
uncomplicated urogenital, anorectal, and pharyngeal gonorrhea [39].  
Though the current recommendations appear to be effective, decreasing global 
susceptibility to ceftriaxone and the prevalence of azithromycin resistance in many 
settings as well as the prohibitive cost of dual-therapy in many resource poor settings 
indicate that dual therapy regimens are more likely short-term solutions. Additionally, 
multidrug resistant and extensively drug resistant strains have been reported throughout 
the world [242], further validating fears of untreatable gonorrhea. Importantly, 
gonococcal infection elicits no protective immunity and there is no vaccine for 
preventative measures [277]. Thus, strategies to treat and combat the spread of 
antimicrobial resistant gonorrhea are a top national and international priority.   
 
V. N. gonorrhoeae virulence factors 
N. gonorrhoeae expresses an array of surface molecules that help mediate its 
interaction with the human host and successfully cause infection. These structures 
contribute to adherence and invasion of mucosal sites as well as immune evasion and 
so are briefly discussed below.   
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A. Type IV Pilus 
Type IV pili are filamentous polymers six nanometers in diameter and several 
micrometers in length that extrude from the cell surface [162].Several genes are 
involved in the biogenesis, assembly and disassembly of pili. The pilus fiber is mainly 
comprised of individual subunits of the major pilin protein, PilE, arranged in a helical 
configuration. Minor pilin proteins such PilC, PilV and PilX are also incorporated into the 
pilus structure and modulate function [250]. PilD a peptidase/transmethylase, processes 
the prepilin precursor and facilitates the incorporation of pilin subunits into the growing 
fiber. PilQ forms an outer membrane secretin through which the fiber is extruded and 
PilF and PilT contribute to fiber assembly and disassembly, respectively [265]. Pili have 
multiple roles in gonococcal pathogenesis inducing bacterial self-agglutination [231], 
attachment to eukaryotic cells [162] and twitching motility [163]. Type IV pili also 
facilitate DNA uptake transformation and thereby contribute to the genetic variation [75].   
Type IV pili undergo both phase and antigenic variation. Phase variation occurs 
as a result of slipped strand mis-pairing event that occurs at the polyC-tract within the 
pilE structural gene during DNA replication. The variable length of the polyC region 
results in frame-shift mutation and reversible on/off variation [13, 123]. Antigenic 
variation occurs as a result of high frequency gene conversion between the PilE 
expression locus and one or more antigenically distinct pil genes in silent pil loci (pilS). 
This process is RecA-dependent and uni-directional [95, 123].The pilus fiber can also 
undergo post-translation modification such as glycosylation [220] as well as 
phosphoethanolamine (PEA) and phosphocholine modification, which can modulate its 
function [250]. Phase and antigenic variation and post-translational modification of pilus 
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fibers are thought to inhibit host immune recognition. Antigenic variation of pili is thought 
to be the biggest reason for the failure of a pili based vaccine to elicit protection [24, 
250].   
B. Porin 
Neisserial porins are the most abundant outer membrane protein in Neisseria. 
Like other members of the Gram-negative porin superfamily, neisserial porins are 
comprised of three polypeptide subunits that form β-barrels and trimerize to form the 
native porin structure, which facilitates the passage of small nutrients and waste 
products across the outer membrane. Neisseria porins are anion selective and voltage-
gated [272]. N. meningitidis expresses two porins: class I (PorA), which is phase 
variable [245] and either class 2 or class 3 (PorB). The limited antigenic variability of 
porins form the basis of the neisserial serotyping system [74]. In N. gonorrhoeae, PorA 
exists as a pseudogene due to mutations within the promoter and coding regions [69]. 
Thus, the gonococcus only expresses 1 porin that is homologous to the meningococcal 
PorB. PorB is further classified as protein IA (PorB1A) or protein IB (PorB1B) [81]. 
In addition to their essential role in cell viability, porins also have roles in 
gonococcal pathogenesis. Porins can spontaneously transfer as a functioning channel 
into model membranes [151, 158] and eukaryotic cell membranes where the resulting 
transient changes in voltage interfere with cell signaling [84, 114, 202]. Neisserial porins 
have also been shown to interact with mitochondria, where it is thought to induce 
calcium influx and apoptosis [167-168]; however, the role of porins in apoptosis is 
controversial since some studies indicate that porin interaction with mitochondria 
protects from apoptosis [156-157].  
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Additionally, neisserial porins have been described to have immuno-modulatory 
functions. Neisserial porins alter neutrophil signaling and inhibit neutrophil degranulation 
and phagocytosis [21, 84]. Neisserial porins also contribute to B-cell activation through 
induction of proliferation and enhancement of antibody secretion [213, 262]. As such, 
PorB has been incorporated into vaccine formulations as an adjuvant [260].  
Porins have also been described to have a role in invasion of epithelial cells. 
PorBIA, which is the expressed por allele in gonococcal strains associated with 
disseminated gonococcal infection, facilitates invasion of epithelial cells [247, 255]. The 
PorBIA serotype is specifically associated with serum resistance [35] and was shown to 
mediate resistance to the alternative and classical complement pathway through binding 
of Factor H and C4b-binding proteins, respectively [189-190]. The PorBIB serotype is 
also able to bind C4b-binding protein indicating that neisserial porins mediate stable 
resistance to complement pathways [188].     
C. Lipooligosaccharide (LOS) 
Like most other Gram-negative bacteria, Neisseria express lipopolysaccharide 
(LPS), which is the main component of the outer leaflet of the outer membrane forming 
an essential barrier to the external environment. The structure of LPS is comprised of 
Lipid A, a lipid moiety which anchors the molecule to the outer membrane, a short 
oligosaccharide core, and a variable length repeating polysaccharide unit or O-antigen. 
The LPS structure in pathogenic Neisseria, lacks the repeating O-antigen and so is 
more accurately termed, lipooligosaccharide (LOS). Though the LOS structure is stably 
expressed, glycosyl transferases, which mediate the addition of terminal sugars to the 
LOS structure and are encoded by the lgt genes, are phase variable [80]. Phase 
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variation of the glycosyl transferases occurs as result of slipped strand mis-pairing 
during DNA replication due to a polyG tract within the coding region of lgt genes [270]. 
The combination of these enzymes results in the antigenic diversity and variable 
expression of LOS terminal structures.   
The oligosaccharide groups on LOS terminal structures are identical to the 
oligosaccharides on host glycosphingolipids [92]. Specifically, the lacto-N-neotetraose 
(LNnT) moiety mimics human paragloboside. In N. gonorrhoeae, the LNnT moiety of 
LOS structures bind to the host asialoglycoprotein receptor to facilitate adherence to 
human sperm [91] and invasion of urethral epithelial cells [90]. This example of 
‘molecular mimicry’ indicates that neisserial LOS contributes to hijacking of host 
receptor systems and immune evasion [92, 248]. 
LOS can be further modified by the addition of sialic acid moieties to the terminal 
lactosamine of LOS. Neisseria cannot synthesize sialic acid, instead it utilizes host 
derived cytidine 5′-monophospho-N-acetyl neuraminic acid (CMP-NANA) as a sialyl 
donor and requires a sialyl transferase for the modification [212]. Because sialic acid 
acceptor sites only exist on certain variants of LOS terminal structures, which are 
regulated by the phase variable expression of glycosyl transferases, sialic acid 
modification is also variable. Sialic acid modification mediates serum resistance and 
specifically, the sialic acid moiety of LOS binds to Factor H, mediating phase variable 
resistance to complement mediated killing [191, 261]. While sialic acid modification 
contributes to serum resistance, it also inhibits invasion of epithelial cells indicating that 
variation of LOS terminal structures can contribute to conversion between invasive and 
serum resistant phenotypes [246]. The phase variation and modification of LOS terminal 
 13 
 
structures implicate a much larger role in gonococcal pathogenesis beyond stabilization 
of the outer membrane, essential for viability.  
D. Opacity (Opa) proteins 
Opacity (Opa) proteins are a family of Neisseria outer membrane proteins that 
mediate invasion of epithelial cells and leukocytes [127, 154, 195, 256]. Opa proteins 
were originally described for their capacity to impart opacity to the colonies that express 
them [229]. While N. meningitidis encodes 4 opa loci, N. gonorrhoeae have 11 that are 
dispersed throughout the genome [16, 219]. The selection of Opa+ gonococci during 
natural and experimental infection [109, 230-231] is indicative of their important role in 
gonococcal infection.  
Expression of Opa proteins is subject to phase variation at the translation level 
as a result of slipped-strand mis-pairing of a pentameric repeat sequence (5’-CTCTT-3’) 
within the signal peptide of the coding region of the gene [219]. Thus, a gonococcus can 
express one or multiple Opas at a time; however, expression of no more than 4 Opas 
have simultaneously been detected in an individual gonococcus [22]. Opa proteins also 
undergo antigenic variation due to recombination events between opa loci [97].  
Opa proteins are ~ 30kDa in size and form eight stranded β-barrel structures with 
four surface-exposed loops [250]. Loops 1, 2 and 3 are variable and the sequence 
diversity in these regions confer receptor specificity. Opa proteins can be categorized 
based on their receptor tropism. A small group of Opas bind to heparin sulfate 
proteoglycans (HSPGs) and extracellular matrix proteins vitronectin and fibronectin, 
while most Opas bind to the human carcinoembryonic related cell adhesion molecule 
(CEACAM) family of receptors [60]. The combined phase and antigenic variation of Opa 
 14 
 
proteins provides important functional diversity via their recognition of specific cellular 
receptors, which mediates tissue tropism and influences interactions with epithelial and 
phagocytic cells. 
 
VI. Iron in the human host 
Iron is an essential element for most living organisms. Iron can exist in two 
readily reversible redox states: ferrous, Fe2+ or ferric, Fe3+. Thus, it is incorporated as a 
co-factor or electron carrier of a wide range of proteins, where it can adopt a redox 
potential from -300 to +700mV depending on its local protein environment [9]. Iron-
containing proteins participate in essential physiological functions such as respiration 
and DNA biosynthesis [9]. While the chemical properties of iron contribute to its 
biological versatility, they also potentiate toxicity. In the presence of oxygen, the 
reduced ferrous iron form is predominate and can activate the Fenton Reaction [Fe2+ + 
H2O2 = OH• + OH- + Fe3+], generating highly reactive free hydroxyl radicals that are 
detrimental to most macromolecules [244].  
Though the human body contains 3-4g total iron, iron is tightly regulated to 
mitigate its potential toxicity. Storage proteins such as ferritin sequester iron 
intracellularly while extracellular iron is carefully chaperoned through the body by carrier 
protein transferrin. The presence of transferrin in plasma, lymph and cerebrospinal fluid 
and lactoferrin in exocrine secretions purge the human host of free iron [258]. In normal 
human plasma, free iron levels are ~ 10-18 M [177]. Thus, the human host is a hostile 
environment for invading microorganisms that require micro molar amounts of iron for 
growth. Additionally, host iron withholding defenses, also termed “nutritional immunity”, 
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in response to infection further limit iron availability by reducing dietary iron absorption 
and plasma iron levels and increasing intracellular iron storage [257]. The ability of 
pathogenic microbes to acquire iron from host sources can therefore be considered a 
critical virulence determinant. In the absence of free iron, host-derived iron binding 
proteins can be biological iron sinks to invading microbes that are capable of utilizing 
them. Some potential iron sources within the human host are briefly described below. 
A. Transferrin 
Transferrin (Tf) is an 80kDa glycoprotein whose primary role is to transport iron 
throughout the body. Tf structure is bi-lobal (C- and N-lobe) and each lobe can bind an 
iron atom, though the N-lobe appears to be predominately occupied by iron in vivo 
[150]. Tf binds to Fe3+ with high affinity (Kd ~ 10-22 M). In serum, Tf is ~30% saturated 
with iron and is present at substantial concentrations (25-44µM); however, only 0.2-
1.3µM is present in mucosal secretions [209]. To facilitate iron trafficking, iron-laden Tf 
binds to the human transferrin receptor (TfR1) expressed on the surface of all iron 
requiring cells [2]. The Tf-TfR1 complex is internalized via receptor mediated 
endocytosis and the endosome is subsequently acidified to release Fe3+. Apo-Tf 
remains associated with the TfR1 and the complex is recycled back to the cell surface 
where Tf is released into serum [150].      
B. Lactoferrin 
Lactoferrin (Lf) is iron binding glycoprotein within the transferrin family. It is found 
in highest abundance in milk, but it also present in other biological fluids including tears, 
saliva, vaginal fluids, semen, nasal and bronchial secretions, bile, gastrointestinal fluids, 
urine [79]. In serum, Lf is present at low levels (3.8-8.8nM), but is a significant 
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component of mucosal secretions at 6-13µM [209]. Like Tf, Lf is ~ 80kDa, bi-lobal and 
can bind Fe3+; however, unlike Tf, Lf retains bound iron in acidic conditions [68]. In 
addition to roles in iron-sequestration, Lf has been attributed a number of other 
physiological roles, one of which is innate immunity [79]. A significant amount of Lf is 
found in the specific granules of polymorphonuclear leukocytes and has demonstrated 
iron-independent antibacterial activity. Proteolytic processing of Lf results in the cationic 
peptide lactoferricin, which is thought to interact with negatively charged structures on 
the surface of bacteria such as LPS and contribute to disorganization of the outer 
membrane resulting in cell lysis [68].      
C. Ferritin 
Excess iron is stored in the intracellular storage protein, ferritin. Ferritin is a 
hetero-polymer comprised of 24 heavy and light polypeptide subunits that assemble to 
form an almost perfectly spherical nano-cage [2]. The mature protein shell is ~450kDa 
with a diameter of 8-12nm and can hold up to 4500 oxygen bound iron atoms [2, 96]. 
Iron is stored in the Fe3+ form in ferritin. Hemosiderin, a degradation product of ferritin 
contains a heterogeneous iron mineralization products and can release iron in acidic 
conditions [179].     
D. Heme/ hemoproteins 
Approximately 70% of the iron content in the human body is within heme, a 
heterocyclic organic ring called porphyrin covalently bound to Fe2+ (heme) or Fe3+ 
(hemin) [203]. Heme solubilizes iron and enhances its catalytic activity; as such it is 
incorporated as a prosthetic group of hemoproteins involved in oxygenation, oxidative 
stress-response, electron transport, oxygen transport, oxygen sensing, and oxygen 
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storage [10]. Over 95% of heme is in hemoproteins, the majority of which is in 
hemoglobin found mainly within erythrocytes [203]. Hemoglobin (Hg) is a tetramer 
comprised of two α- and two β- chains. Each subunit binds to a heme molecule, of 
which the heme-iron can bind to oxygen to facilitate oxygen transport. Though 
intracellular, Hg can be released via spontaneous hemolysis resulting in 80-800nM of 
Hg in serum [209]. However, excess quantities of the tetrameric glycoprotein, 
haptoglobin (Hp) rapidly complexes Hg and removes it from circulation by delivering it 
the endocytic system via receptor-mediated endocytosis [173]. Likewise, any heme 
dissociated from Hg during hemolysis is bound to the glycoprotein hemopexin (Hx) and 
removed from circulation in a receptor-dependent manner [173].  
E. Siderophores 
In response to iron limitation many microorganisms (bacteria, yeast and fungi) 
synthesize and secrete, small (<1kDa) iron chelating molecules termed siderophores 
[193]. These siderophores specifically bind Fe3+ with Kd ~10-22-10-50 M and can thus 
remove iron from host sources such as ferritin, Tf, Lf, but not from heme or 
hemoproteins [193]. Most siderophores are biosynthetically produced by large multi-
enzyme synthases and have a backbone of modified amino acid side chains creating 
the iron-coordinating ligand [47]. They can be classified into one of three groups: 
catecholate, hydroxamate and hydroxycarboxylate [252]. Upon secretion, siderophores 
scavenge free or host protein bound iron in the extracellular environment. The iron-
laden siderophores can then deliver the sequestered iron to microorganisms that 
express siderophore specific receptors.  
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Mammals fight back against bacterial siderophores by producing the lipocalin 
family of proteins termed siderocalins, for siderophore binding lipocalins. Siderocalins 
include lipocalin 1 (Lcn1) or tear lipocalin and neutrophil gelatinase associated lipocalin 
(NGAL or Lcn2, 24p3, Scn). These proteins bind enterobactin-like siderophores, 
preventing bacteria from scavenging iron [54]. Some bacteria go further to modify their 
siderophores via glycosylation, which prevents siderocalin binding [70].  
Another variation of the siderophore theme are hemophores. Hemophores are 
bacterial proteins that bind heme or host hemoproteins with high affinity. They are 
structurally diverse and have different mechanisms of heme coordination. Like 
siderophores, hemophores deliver heme back to the bacteria that secrete them via cell 
surface receptors; however, only the heme moiety is internalized while the hemophore 
is recycled at the cell surface [253].   
 
VII. Iron acquisition systems of Neisseria gonorrhoeae 
As an obligate human pathogen N. gonorrhoeae has evolved a diverse catalogue 
of systems to assimilate iron from the hostile host. Unlike other bacteria N. 
gonorrhoeae, does not secrete any siderophores [259]. Instead it relies on single and 
two-component systems to acquire iron from host derived iron or heme binding proteins.  
A. Two-component systems 
 A schematic of two-component systems for iron acquisition in N. gonorrhoeae 
are depicted in Figure 1. The Tf-iron acquisition system is comprised of a TonB- 
dependent transporter (TdT), TbpA and a surface exposed lipoprotein, TbpB. The 
TbpA/B system is found in most Neisseria; notably it is found in all N. meningitidis and   
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Figure 1. Two-component iron acquisition systems of N. gonorrhoeae. 
Host iron sources transferrin (hTf), lactoferrin (hLf), hemoglobin (Hg), and hemoglobin 
bound to haptoglobin (Hg-Hp) are shown in the extracellular space with their 
gonococcal receptor systems. The TonB-dependent transporters (TbpA, LbpA and 
HpuB) are depicted are as barrels traversing the outer membrane (OM) with a plug 
domain occluding the barrel. The companion lipoproteins (TbpB, LbpB and HpuA) are 
shown attached to the outer leaflet of the OM. The TonB/ExbB/ExbD system is shown 
attached to or imbedded within the inner membrane (IM). TonB interacts with the plug 
domain of TdTs to facilitate iron transport through the TdT barrel. The PBP, FpbA is 
shown localized to the periplasm where it binds ferric iron from TbpA and LbpA and 
shuttles it to the inner membrane permease, FbpB which transports iron into the cytosol 
upon ATP hydrolysis by ATPase, FbpC.     
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Figure 1. Two-component iron acquisition systems of N. gonorrhoeae. 
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N. gonorrhoeae strains [155]. Additionally, the absence of the Tf acquisition system 
attenuated virulence in a human male model of infection indicating the critical role of Tf 
utilization to pathogenesis [52]. TbpA and TbpB are both encoded in an iron repressed 
operon in which tbpB precedes tbpA. The structure of TbpA is consistent with the 
common topology described for all TonB-dependent transporters: a β-barrel comprised 
of 22 amphipathic β-strands, surface exposed loops and a globular plug domain inside 
the barrel [175]. TbpB has a bi-lobal structure; the N- and C-terminal lobes can both can 
bind Tf [62]. Both TbpB and TbpA can bind Tf with nanomolar affinities and remove its 
iron [53, 211]. Only TbpA is required for uptake of iron from Tf, but the presence of 
TbpB makes the process more efficient since TbpB preferentially binds holoTf [6, 50, 
63].        
 The Lf acquisition system is analogous to the Tf acquisition system comprising a 
TdT, LbpA, and a surface exposed lipoprotein, LbpB [18, 20, 208]. Like the Tf 
acquisition system the lbpA/B genes are encoded on an iron repressed operon where 
the lipoprotein precedes the TdT [4]; however, LbpB is subject to phase variation due to 
a polyC-tract within the coding region [18]. The LbpA/B system is present in most 
Neisseria [155]. While present in all N. meningitidis strains, the Lf acquisition system is 
absent in half of gonococcal isolates due to a large deletion of lbpB and the 5’ end of 
lbpA [4]. The Lf acquisition system is not required for virulence, as N. gonorrhoeae 
lacking the LbpA/B are still able to cause infection in men [52].   
The hemoglobin/ haptoglobin (Hg-Hp) acquisition system is another two-
component acquisition system comprised of a TdT, HpuB, and a lipoprotein, HpuA 
present in most Neisseria. Unlike the Tf and Lf systems, which specifically recognize 
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human Tf or Lf, the HpuB/A system recognizes Hg, Hp or Hg-Hp complexes [42-43, 
138, 140]. The system internalizes the heme moiety from Hg which can support use of 
Hg or Hg-Hp as a sole source of iron or heme [141]. Both HpuB and HpuA are required 
for Hg binding and growth in the presence of Hg as the sole iron source [42]. The 
operon encoding hpuB and hpuA is iron repressed and phase varies by virtue of a 
polyG tract within the coding sequence of hpuA [42, 139-140].  
B. Single component systems 
In addition to the two component systems described, Neisseria also encode 
single component systems in which a TdT is the sole surface exposed component. The 
HmbR receptor in N. meningitidis facilitates utilization of Hg and is subject to phase 
variation by virtue of a polyG tract within its coding region [139, 197]. HmbR however, is 
present in N. gonorrhoeae as a pseudogene due to a premature stop codon [197, 222]. 
FetA, another single component iron acquisition system, facilitates the utilization of 
catechol-type siderophores and undergoes phase variation due to a polyC tract in its 
promoter [36, 98]. TdfF is a TdT specific to pathogenic Neisseria [155, 214]. Its 
expression has only been detected in iron repressed conditions in the presence of 
serum [83, 238]. TdfF was found to be important for intracellular survival and is 
hypothesized to facilitate utilization of an intracellular iron source though the ligand has 
not been identified [83]. Gonococcal single component systems for iron acquisition are 
depicted in Figure 2.  
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Figure 2. Single component systems for iron transport in N. gonorrhoeae. 
The TonB-dependent transporters (FetA and TdfF) are depicted are as barrels 
traversing the outer membrane (OM) with a plug domain occluding the barrel. FetA 
facilitates utilization of catechol-type siderophores secreted by neighboring bacteria 
such as enterobactin (Ent, pictured in the extracellular space). The ligand to which TdfF 
binds to support gonococcal survival in cervical epithelial cells is not known. The 
TonB/ExbB/ExbD system is shown attached to or imbedded within the inner membrane 
(IM). TonB interacts with the plug domain of TdTs to facilitate substrate transport 
through the TdT barrel. The PBP, FetB is shown localized to the periplasm where it is 
expected to bind ferric-siderophores and shuttle them to the putative inner membrane 
permease encoded by fetCDEF. The putative PBP, FetB2 encoded near TdfF is 
expected behave similarly to FetB. 
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Figure 2. Single component systems for iron transport in N. gonorrhoeae. 
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C. TonB-dependent transport 
Subsequent to binding of host iron sources at the cell surface, transport of iron or 
iron-chelate through TdTs requires metabolic energy provided by the TonB/ExbB/ExbD 
complex localized to the inner membrane. In Neisseria, tonB, exbB and exbD are within 
an operon and are iron-repressed [19, 64, 106, 224]. TonB has an N-terminal 
transmembrane domain, a proline-rich spacer region that allows it to span the 
periplasmic space and a C-terminal domain essential for interaction with TdTs [125]. 
The mechanism by which energy is transduced to the TdT on the outer membrane is 
not fully resolved. TonB in complex with ExbB and ExbD harnesses energy from the 
proton motive force [184] and is thought to transduce energy to TdTs via interaction with 
the TonB box found on the plug domain of TdTs, resulting in movement of the substrate 
through the channel and into the periplasm [125].  
D. Cytoplasmic transport 
Once in the periplasm, transport of iron or iron-chelates across the cytoplasmic 
membrane requires an ATP-binding cassette (ABC) family transporter comprised of a 
periplasmic binding protein (PBP), and inner membrane permease and ATP binding 
domains [124]. The transport of iron from Tf and Lf into the cytoplasm requires FbpA, 
the PBP of the FbpABC system that binds Fe3+ with a Kd ~ 10-18M [45, 211]. The 
FbpABC operon is also iron repressed [64, 72, 106]. A heme ABC transport system is 
hypothesized to exist in Neisseria but has not been identified. Enterobaction utilization 
also requires the PBP, FetB of the putative ABC transporter FetCDEF, which are all 
transcriptionally linked to FetA [36, 98]. 
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E. Regulation 
All of the TdTs involved in iron/ iron-chelate acquisition are regulated by Fur. 
Generally, Fur acts a repressor. In high iron concentrations Fe2+ binds to Fur, increasing 
its affinity for the specific DNA binding motif, termed Fur box, within promoter of target 
genes [28]. Fe/Fur binding to the Fur box blocks RNA polymerase recruitment inhibiting 
transcription. Fur can also act positively on gene expression through direct and indirect 
mechanisms [274]. FetA, for example is activated by MpeR [98], an AraC-like regulator 
that is Fur repressed [106]. 
F. Uncharacterized TdTs in N. gonorrhoeae 
Additional TdTs in N. gonorrhoeae whose functions have not yet been 
characterized are listed in Table 1. These include TdfG, which is present only in N. 
gonorrhoeae; TdfH, which found in most Neisseria and TdfJ, which is present in all 
Neisseria [51, 155]. Of the TdTs characterized, the majority have roles in iron 
acquisition and are iron repressed [206]. The uncharacterized TdTs of N. gonorrhoeae 
are differentially regulated by iron. TdfG is iron repressed supportive of a role in 
transport of iron or an iron chelate [64, 106, 238]. However, TdfH is not regulated by 
iron, which may imply a function outside of iron acquisition [64, 238]. Transcriptional 
studies indicate that tdfJ is iron-induced, which is also inconsistent with a role in iron 
acquisition [64, 273]. The function of these receptors is further occluded by the fact that 
their closest homologs are heme or siderophores receptors, though their contribution to 
gonococcal heme utilization has not been demonstrated [51, 238]. Furthermore studies 
in N. meningitidis have implicated TdfH and TdfJ in Zn and/or heme acquisition [126, 
225-226], but these phenotypes have not been explored in N. gonorrhoeae.    
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Table 1. Uncharacterized TdTs in N. gonorrhoeae 
Name Predicted size1 Closest homologs Distribution2 Iron repression 
TdfG 136kDa Heme transporters N. gonorrhoeae 
only 
Iron repressed 
TdfH 104kDa HasR and heme 
transporters 
Most Neisseria Not iron 
regulated 
TdfJ 86kDa Siderophore and 
heme transporters 
All Neisseria Iron induced 
1Predicted molecular weight 
2Distribution indicates whether the gene is possessed by some or all Neisseria including 
commensal species 
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VIII. Vaccine Development  
 In light of the rising threat of untreatable gonorrhea, the need for novel therapies 
and a protective vaccine is even more urgent. Gonococcal vaccine development 
strategies have stalled due to the complications of antigenic variation of past vaccine 
targets such as pili and porin during natural infection as well as the immunosuppressive 
effects of natural infection [277]. However, recent insights have revealed that the active 
suppression of adaptive immunity by N. gonorrhoeae can be reversed in vivo by adding 
blocking antibodies against innate immunity-inducing cytokines, resulting in an anti-
gonococcal immune response and protective immunity in a mouse model of female 
genital tract infection [146-147]. These novel insights may propel forward vaccine 
development strategies. As such, the identity of new potential vaccine targets remains 
relevant.   
 The surface exposure, limited sequence variation and wide-spread distribution 
among gonococcal strains indicate that TonB-dependent transporters may be good 
potential vaccine targets. Past work has demonstrated that intranasal vaccination of 
TbpA and TbpB conjugated to the B subunit of cholera toxin elicits mucosal and serum 
antibodies that are bactericidal in the presence of human complement in the mouse 
model of female genital tract infection [186]. Given the promising results with TbpA and 
TbpB, the use of other TdTs as vaccine antigens may also be successful. For example, 
ZnuD, the meningococcal TdfJ homolog, was shown to elicit cross reactive bactericidal 
antibodies against genetically distinct meningococcal strains when used to immunize 
mice and guinea pigs in an outer membrane vesicle vaccine formulation [103]. 
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IX. Research Objectives 
 The goal of the research described in this thesis is to characterize the regulation 
and function of the gonococcal TonB-dependent transporters TdfG, TdfH and TdfJ. 
Three main objectives were pursued to achieve this goal. First, the role of these 
receptors in gonococcal heme utilization was assessed. Next, the regulation of these 
receptors in response to iron and zinc was explored. Additionally, the regulation of these 
TdTs by known virulence regulators was evaluated. Finally, the contribution of TdfH and 
TdfJ to gonococcal Zn acquisition was determined. These studies have ascribed 
functions to TdfH and TdfJ and characterized a novel gonococcal defense strategy 
against host mediated nutritional immunity. Additionally, these studies have identified a 
novel regulator of TdfG and revealed strain specific regulation of TdfH. Together the 
work described herein will provide insight into the contribution of these receptors to 
gonococcal pathogenesis, which may be useful for the development of novel protective 
and/or therapeutic strategies.     
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Chapter 2: Materials and Methods 
 
 
I. Bacterial strains and routine maintenance 
Strains and plasmids used in this study are listed in Table 2. All plasmids were 
propagated in E. coli TOP10 cells (Invitrogen). E. coli was cultured in Luria-Bertani (LB) 
broth media [14-15] with antibiotic selection at 100µg/mL for ampicillin (Sigma), 34 
µg/mL for chloramphenicol (Sigma), or 50µg/mL for kanamycin (Sigma). N. 
gonorrhoeae was routinely maintained on GC medium base (GCB; Difco) agar with 
Kellogg’s supplement I [118] and 12µM Fe(NO3)3 at 37ºC in 5% CO2 atmospheric 
conditions. N. gonorrhoeae growth conditions for specific assays are described below. 
II. Gonococcal mutant construction 
A. TdT double mutants, MCV935 & MCV936 
To generate double mutants incapable of expressing both TdfG and TdfJ or TdfH 
and TdfJ in the FA1090 background, the XbaI and SacI flanked tdfJ fragment from 
pVCU703 was first sub-cloned into pVCU403, which contains gonococcal DNA uptake 
sequence [176]. The resulting plasmid, pVCU937, was subjected to random transposon 
mutagenesis using the Ez-Tn5™<Kan-2> Kit (Epicentre). Kanamycin resistant clones 
were screened via restriction mapping for Tn5<Kan-2>insertion within the tdfJ gene 
fragment; the insertionally mutagenized plasmid employed subsequently was named 
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pVCU938. Gonococcal strains MCV660 and MCV661 contain an Omega insertion 
within the coding region of genes  tdfG and tdfH, respectively in an FA1090 background 
and have been described elsewhere [83]. MCV660 and MCV661were transformed with 
pVCU938 and transformants were selected on GCB agar supplemented with 50µg/mL 
kanamycin. Chromosomal mutation was confirmed via PCR with MyTaq polymerase 
(Bioline) according to manufacturer’s instructions. Primers used in this study are listed 
in Table 3. The following pairs of gene specific primers were used: oVCU199/200, tdfG; 
oVCU201/202, tdfH; oVCU203/204, tdfJ. The resulting strains were designated 
MCV935 and MCV936. 
B. Heme auxotrophic mutants 
To generate heme auxotrophs in FA1090, tonB, and TdT mutant backgrounds 
we obtained pUNCH1304, which contains the hemH gene disrupted with a 
chloramphenicol acetyltransferase cassette (CAT) [237]. Gonococcal strains FA1090, 
FA6916, MCV656, MCV660, MCV661, MCV662 and MCV935, which have been 
described previously [52, 83, 169], were transformed with pUNCH1304 and 
transformants were selected on GCB agar plates supplemented with 16µM hemin 
(Sigma) and 1µg/mL chloramphenicol. Mutations were confirmed via PCR as previously 
described with hemH specific primers oVCU793 and oVCU794 (Table 3). The resulting 
strains, MCV937, MCV939, MCV943, MCV944, MCV945, MCV946 and MCV947 and 
their genotypes are listed and Table 2.       
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C. FA19 and FA1090 zur mutants, MCV963 & MCV964 
To construct the gonococcal zur mutant, we obtained zur::kan from Dr. Alastair 
G. McEwan at University of Queensland, which contains the full length zur gene in the 
SmaI site of pUC19 interrupted by a kanamycin resistance cassette. This plasmid was 
linearized with ScaI and used to transform gonococcal strains FA19 and FA1090. 
Transformants were selected on GCB agar plates supplemented with kanamycin at 
50μg/mL and the chromosomal mutation confirmed via PCR as previously described 
with zur specific primers oVCU801 and oVCU802. The resulting strains were named 
MCV963 (FA19 zur) and MCV964 (FA1090 zur).  
D. tdfH complimented derivative, MCV956 
Gonococcal strain MCV927 contains an Omega insertion within the coding region 
of the tdfH gene in an FA19 background and has been described elsewhere [227]. To 
generate a complemented derivative of MCV927, the full length tdfH gene including its 
native ribosome binding site (RBS) was PCR amplified from FA1090 chromosomal DNA 
using the following primers: oVCU807 and oVCU798. The amplicon was cloned into 
pCR2.1 using the TOPO TA cloning kit (Invitrogen) according to manufacturer’s 
instructions to generate pVCU944. The tdfH sequence was confirmed by sequencing 
and pVCU944 was digested with restriction endonucleases ScaI and PmeI to isolate the 
tdfH fragment, which was then purified and inserted at the PmeI site of pGCC4 [160]. 
The proper orientation of tdfH in the resulting plasmid, pVCU945, was verified by 
restriction mapping with ScaI and KpnI. For gonococcal transformation, pVCU945 was 
digested with NotI and the fragment containing tdfH, lctP, aspC and the erythromycin 
resistance cassette was purified and used to transform MCV927. Transformants were 
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selected on GCB agar plates supplemented with 1µg/mL erythromycin. The resulting 
strain, MCV956, contains the chromosomal tdfH mutation and an ectopically inserted 
copy of the wild type tdfH gene preceded by its native RBS under the control of a lac 
promoter. 
E. Opaless tdfH mutant, MCV955 
A tdfH mutant in the FA1090 Opaless background [12] was constructed for NET 
survival studies. To generate this mutant, the XbaI and SacI flanked tdfH fragment from 
pVCU702 was sub-cloned into pVCU403. The resulting plasmid, pVCU947, was also 
subjected to Ez-Tn5<Kan-2> random transposon mutagenesis, restriction mapped for 
Tn5<Kan-2> insertion within the tdfH gene fragment and the insertionally mutagenized 
plasmid was named pVCU948. FA1090 Opaless was then transformed with pVCU948 
and transformants were selected on GCB agar supplemented with 30µg/mL kanamycin, 
resulting in strain MCV955. 
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Table 2. Strains and plasmids used in this study 
Strain or plasmid Genotype and/or relevant characteristics Ref. or source 
N. gonorrhoeae   
FA19 Wild type [204] 
FA1090 Wild type (ΔlbpA, HpuAB off)  [169] 
Opaless FA1090 ΔopaA-K [12] 
Δnuc Opaless Δnuc (Kanr) [115] 
FA1090 misR FA1090 misR::aphA-3 (Kanr) Dr. William M. Shafer 
FA19 misR FA19 misR::aphA-3  (Kanr) Dr. William M. Shafer 
FA6916 FA1090 Δtbp [52] 
MCV304 FA1090 mpeR::aphA-3(Kanr) [98] 
MCV404 FA1090 fur-1 (Ermr)  Dr. Aminat T. Oki 
MCV650 FA19 tonB::Ω (Strr, Spcr) [227] 
MCV656 FA1090 tonB::Ω (Strr, Spcr) [83] 
MCV660 FA1090 tdfG::Ω (Strr, Spcr) [83] 
MCV661 FA1090 tdfH::Ω (Strr, Spcr) [83] 
MCV662 FA1090 tdfJ::Ω (Strr, Spcr) [83] 
MCV926 FA19 tdfG::Ω (Strr, Spcr) [227] 
MCV927 FA19 tdfH::Ω (Strr, Spcr) [227] 
MCV928 FA19 tdfJ::Ω (Strr, Spcr) [227] 
MCV935 FA1090 tdfG::Ω tdfJ::Tn5 (Kanr, Strr, Spcr) This Study 
MCV936 FA1090 tdfH::Ω tdfJ::Tn5 (Kanr, Strr, Spcr) This Study 
MCV937 FA1090 tdfG::Ω tdfJ::Tn5 hemH::cat (Cmr, Kanr, Strr, 
Spcr) 
This Study 
MCV939 FA1090 tdfJ::Ω hemH::CAT (Cmr, Strr, Spcr) This Study 
MCV943 FA1090 tdfG::Ω hemH:: CAT (Cmr, Strr, Spcr) This Study 
MCV944 FA1090 hemH:: CAT (Cmr) This Study 
MCV945 FA1090 tdfH::Ω hemH::CAT (Cmr, Strr, Spcr) This Study 
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MCV946 FA1090 tonB::Ω hemH:: CAT (Cmr, Strr, Spcr) This Study 
MCV947 FA1090 Δtbp hemH:: CAT (Cmr) This Study 
MCV955 FA1090  ΔopaA-K tdfH::Tn5 This Study 
MCV956 FA1090  tdfH::Ω tdfHc(Ermr, Strr, Spcr) This Study 
MCV963 FA19 zur::kan (Kanr) This Study 
MCV964 FA1090 zur::kan (Kanr) This Study 
E. coli   
TOP10  F‒ mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacΧ74 recA1 araD139 Δ(ara-leu)7697galU galK 
rpsL (Strr) endA1 nupG 
Invitrogen 
Rosetta™ (DE3) F–ompThsdSB(rB– mB – ) galdcm (DE3) pRARE2 (Cmr 
) 
Novagen 
Plasmids   
pCR2.1 TOPO Cloning plasmid (Kanr Ampr) Invitrogen 
pUC18 Cloning plasmid (Ampr)  Invitrogen 
pGCC4 Complementation plasmid (Kanr Ermr) [160] 
pUC19zur::kan pUC19 containing full length zur disrupted by Kan 
cassette  
Dr. Alastair G. 
McEwan 
pUNCH1304 pCRII derivative containing hemH::CAT [237] 
pETR7 pET24d(+) w/ rHusA (excl. signal peptide) + C-term. 
thrombin cleavage site and 6xHis(Kanr) 
[77] 
pVCU403 pUC18 with gonococcal uptake sequence (Ampr) [176] 
pVCU702 pCR2.1 containing tdfH fragment  [83] 
pVCU703 pCR2.1 containing tdfJ fragment  [83] 
pVCU937 pVCU403 containing tdfJ fragment from pVCU703 This study 
pVCU938 pVCU937 with tdfJ disrupted by Ez-Tn5<Kan-2> This study 
pVCU944 pCR2.1 containing full length tdfH + native RBS  This study 
pVCU945 pGCC4 containing tdfH allele from pVCU944 This study 
pVCU947 pVCU403 containing tdfH fragment from pVCU702 This study 
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pVCU948 pVCU947 with tdfH disrupted by Ez-Tn5<Kan-2> This study 
Amp, ampicillin; Cm, chloramphenicol; Erm, erythromycin; Kan, kanamycin; Spc, 
spectinomycin; Str, streptomycin 
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Table 3. Primers used in this study  
Primer Target Sequence  
oVCU199 tdfG 5′-GGC GCA TTG GCT TTT GCA GAC ACC CCG AAC-3′ 
oVCU200 tdfG 5′-GGC GCA TTG GCT TTT GCA GAC ACC CCG AAC-3′ 
oVCU201 tdfH 5′-GGC AGC GAG GCG CAG ATA CAG GTT TTG GAA-3′ 
oVCU202 tdfH 5′-GCG CCA GGT TTT CCC GCC AGC TTT TAT CAT-3′ 
oVCU203 tdfJ 5′-CCC CTC CTC GCC CAA GCG CAT GAA ACT GAG-3′ 
oVCU204 tdfJ 5′-GGC GTG GCA ATC ATC GTA TTC GTG GCT GTG-3′ 
oVCU793 hemH 5’-CGC AAA CCG CAT TAC CTG AT-3’ 
oVCU794 hemH 5’-ATT GGC TTT GGA ACG ATA CG-3’ 
oVCU798 tdfH 5’- CAC AGT TTA AAC AAA CGC GGG CTG-3’ 
oVCU801 zur 5’-TCA GTA CTA CCG CCT CCT GTC GT-3’ 
oVCU802 zur 5’-GTC GTT TAA ACA GGT GGG ACT TTG GT-3’ 
oVCU807 tdfH 5’- GGG CAG TAC TGA GGA AAA TAT GAG ATC T-3’ 
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III. Limited heme growth assays 
 For limited heme growth in Wade-Graver (GW) media, GW media was prepared 
as previously described [251] except that Supplement A was treated with Chelex-100 
(50g per 500mL) before being added at a 1:2 v/v ratio to normal strength M199 (Sigma 
Aldrich). Gonococcal strains were first grown in the partially chelexed GW media until 
log-phase growth was achieved. At log phase, gonococci were diluted to OD600 of 0.02 
in fresh partially chelexed GW media and transferred to a 96-well micro titer plate. Each 
well was supplemented with iron specific chelator, Desferal (deferroxamine mesylate; 
Sigma Aldrich) and hemin to a final concentration of 10µM and 5µM, respectively and 
contained a total volume of 100µL. Hemin stock solutions of 5mg/mL were made in 
0.1M NaOH, filter sterilized (0.22µm) and stored at 4°C in the dark. The micro titer plate 
was incubated at 37°C and 5%CO2 with vigorous shaking and OD600 readings were 
collected every 2 hours for 6 hours. For determination of viable bacteria, 20µL of culture 
were recovered from wells, serially diluted, and spot platted onto GCB agar plates. After 
incubation overnight at 37°C and 5%CO2, CFU of recovered gonococci were 
enumerated. 
 Individual colonies of heme auxotroph mutants from GCB agar plates 
supplemented with 16µM hemin were grown in chemically defined media treated with 
Chelex 100 (Bio-Rad), CDM, [259] supplemented with 1µM heme until log-phase growth 
was achieved. At log phase, cultures were diluted to OD600 of 0.02 in fresh CDM and 
transferred to a micro titer plate. Each well was supplemented with hemin at a final 
concentration of 5µM. The micro titer plate was incubated at 37°C, 5% CO2 and growth 
as monitored via OD600 readings every 2 hours for 6 hours.  
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IV. Expression and purification of P. gingivalis hemophore, HusA 
 The plasmid pETR7, which contains recombinant HusA, P. gingivalis 
hemophore like protein was obtained from Dr. Neil Hunter at Westmead Centre for Oral 
Health and has been described previously [77]. Starter cultures of E. coli expression 
strain Rosetta™ (DE3) containing pETR7 were grown in LB broth media with kanamycin 
(LB-Kan) overnight at 37°C with vigorous shaking. The following day, starter cultures 
were centrifuged at 4,000 x g for 10 minutes and the bacterial cell pellet was re-
suspended in fresh LB-Kan. The entire starter culture was used to inoculate 1L of LB-
Kan, which was grown in at 37°C with vigorous shaking until an OD600 of 0.6 was 
achieved. IPTG was then added at a final concentration of 0.5mM to induce protein 
expression for 3 hours. After induction, bacterial cells were harvested by centrifugation 
at 5,000 rpm for 30 minutes at 4°C. Cell pellets were washed with sterile 1X PBS, pH 
7.2 and centrifuged at 5,000 rpm for 15 minutes. Supernatants were discarded and cell 
pellets were dried, weighed and stored at -80°C overnight. 
 For protein purification, bacterial pellets were thawed on ice an re-suspended in 
cold native lysis buffer (50mM NaH2PO4, 300mM NaCl, 10mM Imidazole [pH 8.0]) at 
5mL buffer/1g pellet. 1X Protease Inhibitor Cocktail (Roche) and 1mg/mL lysozyme was 
added before cultures were incubated for 30 minutes on ice. The cellular mixture was 
sonicated (5x, 30 sec pulse, 1 minute pause between pulses) and the lysate centrifuged 
at 10,000 rpm for 20 minutes at 4°C to remove debris. The cleared lysate was then 
incubated with pre-washed 50% Ni-NTA agarose resin (Qiagen) overnight at 4°C. On 
following day, the loaded Ni-NTA resin was packed into a polyprep column (Bio-Rad) 
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and the flow through collected. The column was washed twice with 5mL wash buffer 
(50mM NaH2PO4, 300mM NaCl, 20mM Imidazole [pH 8.0]) that was collected. The 
recombinant protein was eluted from the column with elution buffer (50mM NaH2PO4, 
300mM NaCl, 250mM Imidazole [pH 8.0]). The column was rinsed with 1X PBS before 
all sample fractions were stored at 4°C until SDS-PAGE analysis. Protein 
concentrations of eluted samples were determined using the BCA Protein Assay Kit 
(Pierce) according to manufacturer’s instructions. Before use in growth assays, purified 
rHusA protein, was loaded with heme (2:1 molar ratio) and un-bound heme was 
removed by dialysis (250mM NaCl, 100mM Tris [pH8.0]). 
 
V. Hemophore utilization assay 
 CDM agarose plates treated with 10µM Desferal to chelate excess iron were 
inoculated with gonococcal strains using a sterile Darcon swab (Puritan). A sterile 
pipette was used to bore wells into the solidified media. Subsequently, 20µL of various 
iron solutions including heme loaded HusA at indicated concentrations were added to 
each well before incubation at 37°C in 5%CO2 atmosphere overnight. The following day, 
plates were recovered and evaluated for growth around each iron source.         
 
VI. Bacterial growth conditions for regulation studies 
A. Iron replete and depleted conditions 
Gonococcal strains were grown in GCB broth containing Supplement I until log-
phase growth was achieved. At log-phase, 24µM Fe (NO3)3 or 100µM Desferal were 
added for iron replete and depleted conditions, respectively. All liquid cultures were 
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grown at 37ºC with 5%CO2. Cultures were grown for 2 hours at the described condition 
before whole cell lysates were harvested.  
B. Varied Zn concentrations  
Gonococcal strains were grown in CDM until log phase growth was achieved. At 
log-phase cultures were before back diluted and Fe(NO3)3, ZnSO4 and/or Zn specific 
chelator N,N,N’N’-Tetrakis-(2pryidylmethyl)-ethylenediamine (TPEN; Sigma) were 
added at the stated concentrations and grown for 4 hours before whole cell lysates were 
harvested. Stock solutions of TPEN were dissolved in 100% ethanol and stored at -
20°C. Subsequent working solutions were diluted in deionized water, filter sterilized 
(0.22µm) and stored short-term at 4°C.     
C. Zn replete and depleted conditions  
Gonococcal strains were grown in GCB broth media containing Supplement I 
until log-phase growth was achieved. At log phase, ZnSO4 or TPEN were added at a 
final concentration of 25µM for Zn replete and depleted conditions, respectively. 
Cultures were grown for 4 hours at the described conditions before whole cell lysates 
were harvested. 
 
VII. Protein analysis methods  
A. Whole cell lysate preparation 
Gonococcal whole cell lysates were collected by centrifuging cultures of 
standardized density at 21, 000 x g for 10 minutes; gonococcal cell pellets were then re-
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suspended in Laemmli solubilizing buffer [128] and stored at -20°C until use. 
Immediately prior to SDS-PAGE, whole cell lysates were treated with 5% β-
mercaptoethanol, drawn through a 28-gauge syringe to reduce viscosity and boiled for 3 
minutes.  
B. SDS-PAGE and Coomassie stain   
Protein samples were resolved by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) on 7.5% or 15% polyacrylamide gels using a Mini-Protean 
III apparatus (Bio-Rad). To detect purified proteins, SDS-PAGE gels of separated 
proteins were stained with Coomassie blue (0.25% Coomassie R-250, 50% methanol, 
10% glacial acetic acid) for 1 hour and de-stained in 20% methanol and 5% acetic acid 
overnight at room temperature to minimize background staining.      
C. Western blot analysis 
Proteins separated on SDS-PAGE gels were transferred to nitrocellulose 
membranes (GE Healthcare Life sciences) in 20mM Tris base, 150mM glycine and 20% 
methanol [234] in a submerged transfer apparatus (Bio-Rad) at constant current of 
28mA for 16 hours.  Membranes were stained with Ponceau S solution (0.1% w/v 
Ponceau S, 5% acetic acid) for 10-12 minutes to confirm equal protein loading of lanes 
before immunodetection of specific proteins. For TdfG detection, membranes were 
blocked with 5% bovine serum albumin (BSA) in a high salt Tris-buffered saline (TBS) 
(20mM Tris, 500mM NaCl, [pH 7.5] 0.05% Tween 20), probed with polyclonal antiserum 
against TdfG [238] and washed with high salt TBS followed by incubation with 
secondary antibody conjugated to alkaline-phosphatase (AP) (Bio-Rad). Blots were 
developed with the nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-
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indolylphosphate (BCIP) system (Sigma). For TdfH detection, membranes were blocked 
with 5% BSA in a high salt TBS, probed with polyclonal antiserum against TdfH [238] 
and washed with high salt TBS followed by incubation with AP conjugated secondary 
antibody. Blots were developed with NBT/BCIP. For TdfJ detection, we generated 
polyclonal anti-peptide antibodies (New England Peptides) against regions predicted to 
correspond to Loop 2 (sera 116, 117) and Loop 5 (sera 118, 119) after alignment of 
TdfJ to a 2D-topology model of TbpA. Membranes were blocked with 5% skim milk in a 
low salt TBS (50mM Tris, 150mM NaCl, [pH 7.5]), probed with serum 117 and washed 
with low salt TBS before being incubated with secondary antibody conjugated to 
horseradish peroxidase (Southern Biotech). Blots were developed with Pierce-ECL-2 kit 
(Thermo Scientific). For TbpB detection, rabbit anti-TbpB primary antibody [185] was 
used after blocking with 5% skim milk. Blots were then washed with low salt TBS before 
incubation with secondary antibody conjugated to AP and developed with NBT/BCIP. 
 
VIII. Enumeration of bacterial growth in Zn replete and depleted conditions 
Gonococci were grown until log-phase growth was achieved in Zn restricted rich 
media, GCB broth containing Supplement I, 12µM Fe(NO3)3 and 12.5µM TPEN (GCB + 
supplement I, Fe, TPEN). At log phase, cultures were back-diluted and were not further 
treated to represent Zn depleted conditions or were treated with ZnSO4 (18.75μM) for 
Zn replete conditions. After growth for 6hours, bacterial cells were harvested by 
centrifugation at 4,000 x g for 15minutes at 4ºC, washed twice with cold PBS, 1mM 
EDTA and re-suspended in PBS before being serially diluted and spot plated on GCB 
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agar plates supplemented with V-C-N Inhibitor (BD BBL™). Plates were incubated at 
37ºC and 5% CO2 for 16 hours before CFUs were enumerated. 
 
IX. Calprotectin growth assay 
 Purified recombinant human calprotectin (CP) was obtained from Dr. Walter 
Chazin at Vanderbilt University. CP was stored in 20mM Tris pH 8.0 100mM NaCl 
10mM β-mercaptoethanol buffer solution and kept at -80°C. Aliquots were thawed on 
ice immediately prior to use and stored short-term at 4°C to prevent multiple freeze-
thaw cycles. For CP growth assays, gonococci were first grown in CDM until log phase 
growth was achieved. At log phase, cultures were diluted to OD600 of 0.02 and 
transferred to a 96-well micro titer plate. Each well contained 7.5μM 30% saturated 
human transferrin (hTf) as the sole iron source, 2.5μM apo-bovine transferrin (bTf) to 
sequester residual iron and 1μM TPEN for Zn chelation. In some cases, 2mM IPTG was 
also added to induce TdfH expression in MCV956. Some wells were further 
supplemented with either CP+ Zn (10µM CP, 5µM ZnSO4) or 5µM ZnSO4 alone. The 
micro titer plate was incubated at 37ºC and 5% CO2 with vigorous shaking and OD600 
readings were collected every 2 hours for 6-8 hours. 
 
X. Whole cell calprotectin binding assay 
Gonococcal strains were grown in CDM treated with 24μM Fe(NO3)3 until log-
phase growth was achieved. At log phase, cultures were back-diluted and 1μM TPEN 
was added. 2mM IPTG was also added when indicated to induce TdfH expression in 
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MCV956. Cultures were grown in the described conditions for 4 hours before being 
applied to nitrocellulose membranes using a dot-blot apparatus (Bio-Rad). Dried 
membranes were blocked for 1hour with 5% skim milk in low salt TBS before being 
incubated with CP + Zn (0.17µM CP, 0.01µM ZnSO4) in blocker. After washing with low 
salt TBS, blots were probed for CP using rabbit anti-s100A9 polyclonal antibody 
(Thermo-Scientific) and secondary antibody conjugated to AP. Dot blots were then 
developed with NBT/BCIP. For densitometry, replicate blots were scanned and 
intensities of individual dots were quantitated using NIH ImageJ [207]. Quantitated 
intensities were normalized to wild type and expressed as % CP binding.     
 
XI. Zn accumulation assay 
Gonococcal strains were first grown in Zn restricted rich media(GCB + 
supplement I, Fe, TPEN) until log-phase growth was achieved, at which point cultures 
were back diluted and either treated with 18.75μM ZnSO4 (Zn replete) or no further 
addition (Zn deplete). For Zn accumulation in the presence of CP, cultures were treated 
with CP + Zn (2µM CP, 1µM ZnSO4) after back dilution. Cultures were grown for 6 
hours in the described conditions before cells were harvested by centrifugation at 4ºC 
for 15 minutes at 4,000 x g and washed twice with cold, chelexed PBS supplemented 
with 1mM EDTA. Bacterial cells were then re-suspended in undiluted Trace Metal 
Grade Nitric Acid, heated at 95ºC for 2 hours, and cooled at room temperature 
overnight. For analysis, samples were diluted 12.5 or 22-fold in chelexed deionized 
water. Metal composition was determined using an MPX Vista Inductively Coupled 
Plasma-Optical Emission Spectrometer (Varian, Inc.). To determine the concentration of 
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metals associated with the cells, a standard curve was generated with a 10μg/mL multi-
element standard (CMS-5; Inorganic Ventures) diluted in chelexed deionized H2O and 
then serially diluted twofold in 1% nitric acid to generate dilutions ranging from 
0.640µg/mL to 0.020µg/mL. Cell pellets from parallel cultures were re-suspended in 
PBS, treated with 5% SDS and vortexed for 30 sec for lysis. Protein concentrations 
were determined using BCA kit.                      
 
XII. NET survival assay, performed in the laboratory of Dr. Alison Criss at 
University of Virginia 
Neutrophils were purified from venous blood collected from healthy donors 
according to a protocol approved for use in the laboratory of Dr. Alison Criss by the 
University of Virginia Institutional Review Board for Health Science Research. Viable 
exponential-phase gonococci were obtained by sequential dilution in rich medium as 
previously described [55] except at the final dilution, cultures were re-suspended in 
phenol red-free Roswell Park Memorial Institute (RPMI) with 1μM TPEN and grown to 
an OD550 of 0.4. Bacterial suspensions were then centrifuged at 10, 000 x g for 3 
minutes and washed once with RPMI before exposure to neutrophils. Survival of 
gonococcal strains upon exposure to PMA stimulated neutrophils treated with 
cytochalasin D only or cytochalasin D plus DNase I, was determined as previously 
described [115]. Briefly, neutrophils were seeded in 24-well plates and treated with 
20nM PMA for 15 minutes at 37°C in 5% CO2. One set of wells was treated with 
10µg/mL cytochalasin D (Sigma), while another set was treated with cytochalasin D and 
1 U of DNase I for, each for 15 minutes. Neutrophils were then exposed to Opaless 
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parent, MCV955 (tdfH) or Δnuc gonococci grown as described above at a multiplicity of 
infection (MOI) of 1 for 1 hour. After infection, well contents were serially diluted and 
plated for CFU enumeration. Bacterial survival is expressed as a percentage of the 
initial inocula per well.   
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Chapter 3: The role of TonB-dependent transporters: TdfG, TdfH and TdfJ in 
heme acquisition 
 
 
 
I. Introduction 
As an essential co-factor for many enzymes functioning in crucial cellular 
processes within all kingdoms of life, iron is an indispensable nutrient for most 
organisms. In aerobic conditions, iron is present in the ferric (Fe3+) oxidized form but is 
poorly soluble. The reduced ferrous (Fe2+) form is much more soluble but can catalyze 
the production of free oxygen radicals which are highly toxic to macromolecules through 
the Fenton reaction. As such, iron levels are tightly controlled to maintain iron 
homeostasis in vertebrates and free iron is scarce. Instead, iron is sequestered 
intracellularly by the iron storage protein ferritin and heme bound to hemoproteins. 
Extracellular iron is in the ferric form and is tightly bound to iron transport protein 
transferrin as well as lactoferrin present in mucosal secretions [209]. For a bacterial 
pathogen to colonize a mammalian host, it must be able to assimilate iron from one or 
more these host iron sources [254].   
Approximately 70% of the iron within the human body is bound to heme [203]. 
Heme solubilizes iron and increases its catalytic ability: a property harnessed as the 
prosthetic group of intracellular hemoproteins such as hemoglobin (Hg), myoglobin and 
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cytochromes to function in electron transport as well as oxygen transport, sensing and 
storage [10]. Heme itself can be toxic due to its chemical properties and ability to 
partition into lipid membranes [221]. Thus, free heme is rarely available in vertebrate 
hosts. Small amounts of extracellular heme can be found in blood Hg from lysed 
erythrocytes [173]. However, Hg is rapidly bound by serum protein haptoglobin (Hp) 
[105]. The Hg-Hp complex is cleared from serum in a receptor mediated mechanism by 
monocytes that express receptor CD163 [173]. The globin components of the Hg-Hp 
complex are degraded in the lysosome and the heme detoxified while CD163 is 
recycled to the plasma membrane to continue to function in Hg clearance and thus 
mitigation of heme-mediated oxidative damage [173]. Likewise, free heme dissociated 
from hemoglobin or other hemoproteins is tightly bound by various serum heme binding 
proteins including high and low density lipoprotein (HDL and LDL, respectively), serum 
albumin, hemopexin (Hx) and α1-microglobulin [11]. Similar to Hg-Hp clearance, Hx 
facilities free heme uptake and subsequent degradation upon interaction with receptor 
CD91, which triggers receptor mediated endocytosis in macrophages and hepatocytes 
[11].  
Despite the rapid recycling of heme and Hg from serum, 80-800nM of Hg can be 
found in plasma [209] and can be a significant source of iron, albeit protein bound and 
heme associated. Thus, pathogenic bacteria have developed strategies to assimilate 
iron from heme/ hemoproteins. Bacterial heme acquisition systems can be classified 
into two categories. The first category relies on the secretion of hemophores, bacterial 
hemoproteins that scavenge heme from the extracellular environment that is then 
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relayed back to the bacteria through specific receptors. The second category involves 
receptors that directly bind to heme or host heme-containing proteins [254]. 
The secretion of hemophores is mostly limited to Gram-negative bacteria but has 
been described in one Gram-positive pathogen, B. anthracis [10, 66]. Hemophores are 
bacteria-derived proteins that are secreted into the extracellular milieu where they bind 
free heme or host hemoproteins with high affinity. There are two types of hemophores 
described for Gram-negative bacteria: the HasA-type, which has been described in 
pathogens, S. marcescens, P. aeruginosa, P. fluorescens, and Y. pestis [10], or HxuA, 
which is only found in H. influenzae. HasA-type hemophores capture free heme or 
heme from host hemoproteins. Since HasA has higher affinity for heme than host 
hemoproteins, heme is thought to passively transfer from host hemoproteins to HasA 
[253]. Upon interaction with its specific outer-membrane receptor, HasA delivers heme 
to the bacterial cell surface and only the heme molecule is internalized [253]. HxuA 
binds to the serum heme recycling protein, hemopexin (Hx) to provide heme from the 
heme-hemopexin complex. Unlike HasA, HxuA does not display high affinity heme 
binding [73]. Instead, it liberates heme from Hx without heme capture inactivating the 
biological function of Hx [253]. The released heme is then accessible to the nearby 
receptor that facilitates its transport across the outer-membrane. Both HusA and HxuA-
type hemophores require outer membrane receptors for heme internalization. The 
receptors are TonB-dependent transporters consisting of a transmembrane β-barrel with 
22 antiparallel β-strands, extracellular loops that interact with heme/ hemoprotein/ 
hemophore ligand and an N-terminal plug domain that closes the β-barrel pore. The 
transport of heme across the outer membrane requires energy from the 
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TonB/ExbB/ExbD system, so all receptors also contain a “TonB box” motif in the plug 
domain, through which TonB and the receptor interact.  
In direct heme acquisition systems, the TonB-dependent transporter itself directly 
binds to heme and/or host hemoproteins. These TdTs can be substrate specific, 
recognizing only one type of host hemoprotein like the Hg-Hp utilization proteins of H. 
influenzae, P. gingivalis, and pathogenic Neisseria [233]. A subset of these substrate 
specific TdTs are bipartite systems that include a lipoprotein in addition to the TdT for 
utilization of the host hemoprotein as is described for pathogenic Neisseria and P. 
gingivalis [253]. Other direct heme acquisition systems are non-specific and thought to 
directly interact with heme to support heme assimilation from free heme as well as a 
variety of host hemoproteins as is the case for HemR of Y. enterolitica and its 
homologues in B. pertussis, S. dysenteriae, V. cholerae, C. jejuni, B. quintana, and E. 
coli O157:H7 [10]. Over 30 heme receptors have been well-characterized in Gram-
negative bacteria that share a range of sequence similarity anywhere from 20-90% 
[210] indicating a wide range of sequence diversity. Most share a highly conserved 
amino acid motif “FRAP(10X)H(XX)NPNL(2X)E”, which contains an invariable His 
residue thought to coordinate heme [27, 223]. However, some heme TdTs lack this 
motif indicating that additional mechanisms of heme coordination exist [203, 233]. To 
fully optimize heme utilization from a variety of host heme sources bacteria can adopt 
either of two strategies: expression of a heme acquisition system that has broad 
specificity to a variety of heme sources or expression of multiple receptors for different 
hemoproteins. 
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After transport across the outer membrane of Gram negative-bacteria via TdTs, 
heme is localized in the periplasmic space. ATP-binding cassette (ABC) transporters 
facilitate the transport of heme from the periplasm to the cytosol. These transporters are 
usually comprised of a high affinity periplasmic binding protein (PBP) that shuttles heme 
through the periplasm to an inner membrane permease, through which heme is 
transported to the cytoplasm upon ATP-hydrolysis [203]. The ABC transport system is 
usually encoded within the same operon of the TonB-dependent transporter. Additional 
components of the operon may encode cytoplasmic heme binding proteins which can 
sequester heme and prevent it from catalyzing reactive oxygen species like ShuS of S. 
dysenteriae or shuttle heme to degradative enzyme HemO like PhuS of P. aeruginosa 
[203]. Heme oxygenase, encoded by hemO, which is ubiquitous in nature, catalyzes the 
oxidation of heme into biliverdin, carbon monoxide, and free iron and is critical for iron 
assimilation from heme and for mitigating heme toxicity [10, 233].     
Pathogenic Neisseria express receptors that directly utilize heme from host 
hemoproteins. The HpuB/A system is expressed in both N. meningitidis and N. 
gonorrhoeae. It is comprised of a TonB-dependent transporter, HpuB, and a lipoprotein, 
HpuA, analogous to the bipartite neisserial transferrin acquisition system [138, 140]. 
These genes are co-transcribed in a bi-cistronic operon and are subject to phase 
variation [43, 140]. The HpuB/A system facilitates utilization of Hg or the Hg-Hp complex 
and requires expression of both the lipoprotein and the TdT for Hg utilization [42]. 
Pathogenic Neisseria also encode HmbR, another phase-variable TonB-dependent 
transporter that utilizes only Hg as an iron source; however, it is only expressed in N. 
meningitidis due to a pre-mature stop codon in N. gonorrhoeae [197, 222]. Pathogenic 
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Neisseria cannot utilize heme from Hx or albumin though it is capable of robust growth 
in presence of free heme [65]. A heme ABC transport system has long been postulated 
in Neisseria but has yet to be identified. Genome searches have not revealed an 
obvious heme PBP or ABC transport system [198]. FbpA, a PBP, which is critical for the 
use of iron from transferrin (Tf), lactoferrin (Lf), and Hg is not required for heme 
utilization in Neisseria [119, 237]. In pathogenic Neisseria, the hemO gene, encoding 
heme oxygenase, is upstream of the HmbR receptor and their expression is 
transcriptionally linked. HemO was found to be critical for the use of all heme 
compounds and for the mediation of heme toxicity [278].        
Neither HmbR, HpuB/A, nor TonB are required for the utilization of free heme 
[19, 43, 222, 224]. TonB-independent heme utilization is suggestive of heme passively 
diffusing across the outer-membrane, possibly through the use of porins; but TonB-
independent heme uptake may not be relevant in vivo as large amounts of heme are 
rare in mucosal environments [209]. Thus, the existence of a free heme receptor has 
been speculated in pathogenic Neisseria for some time. Heme-binding proteins 
(HmBPs) isolated from both N. gonorrhoeae and N. meningitidis were suggested to be 
heme specific receptors given the ability of a monoclonal antibody directed against the 
97kDa HmBP to inhibit growth in the presence of heme [131-132, 134]. The genes 
encoding the 97 and 44kDa HmBPs proteins have never been identified, though these 
proteins may be the HpuB/A proteins given their similar size and similar heme binding 
and inhibition profiles [44, 132]. 
There is no evidence that N. gonorrhoeae produces a hemophore, but it may still 
be able to utilize bacterial derived hemophores as it capable of utilizing bacterial derived 
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siderophores via the TdT, FetA [36, 98]. Gonococcal infection occurs at mucosal 
epithelia, primarily of the urogenital tract a host niche rich in both normal and sometimes 
pathogenic bacteria. The female genitourinary tract, for example, contains commensal 
bacteria which help to protect against pathogenic [142]. Bacterial vaginosis (BV), a 
condition in which there is an imbalance between normal ‘good’ and abnormal bacteria, 
is characterized by an increase in vaginal pH and BV-associated bacteria including 
Mycoplasma hominis, Gardnerella vaginalis, Prevotella spp., Mobiluncus spp., and 
Leptotichia/Sneathia [144]. BV has been demonstrated to be a risk factor for N. 
gonorrhoeae infection [263] but the molecular mechanisms underlying the increased 
risk have not been identified. Some BV-associated bacteria are cytotoxic and so can 
help to liberate intracellular nutrients like heme bound to hemoproteins and provide 
these to invading microbes. G. vaginalis, for example, has been shown to secrete a 
hemolysin, termed vaginolysin with lytic activity specific to human erythrocytes, 
neutrophils, and endothelial cells [271]. Sneathia amnii was also reported to have weak 
hemolytic activity and to encode 2 putative hemolysins [93]. Bacteroidetes species 
including Prevotella and Porphyromonas are also heme auxotrophs and thus encode 
hemolysins as well as heme acquisition systems to fulfill this nutritional requirement 
[137, 275]. Thus, it is possible that the cytotoxic and hemolytic activity of BV-associated 
bacteria can provide an environment favorable to gonococcal infection by either 
increasing the abundance of host hemoproteins or even providing bacterial derived 
hemoproteins. 
The role of heme iron utilization in gonococcal pathogenesis is difficult to 
ascertain since expression of known hemoglobin receptors is phase variable and the 
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gonococcus can assimilate iron from other host derived sources. Menstruation is 
however a major risk factor for complicated gonococcal infection as half the number of 
affected women reported DGI symptoms within seven days of the onset of menses 
[196]. It is likely that strategies that contribute to the utilization of heme and 
hemoproteins during menses, when the levels of host heme sources are presumably 
elevated in the female genital tract, could contribute to pathogenesis. Indeed, the 
expression of the HpuB/A system and utilization of Hg and Hg-Hp was found to be 
correlated to the onset of menses in a study examining naturally occurring gonococcal 
infection [5]. These results suggest a selective advantage for gonococci expressing 
HpuB/A in the female genital tract during menses and point to the need to characterize 
any additional receptors that may contribute to heme utilization.  
Given their reported homology to known heme receptors N. gonorrhoeae TdTs 
(TdfG, TdfH and TdfJ) have all been suggested to participate in heme utilization since 
their identification in genome annotations [126, 238]. Table 4 summarizes the data 
reported in the literature on their potential role in heme acquisition. Turner et al. 
assessed the role of TdfG and TdfH in heme acquisition and reported that isogeneic 
mutants unable to express TdfG or TdfH demonstrated no defect in their ability to grow 
with heme as the sole iron source compared to parent strains [238]. Additionally, 
expression of TdfH in an E. coli hemA mutant did not restore heme utilization [238]. E. 
coli hemA is a heme auxotroph incapable of de novo heme synthesis and therefore 
requires uptake of exogenous heme through a heme receptor to support growth in the 
presence of heme. The ability of putative heme receptors to restore growth in the 
presence of heme upon expression in E. coli hemA has served as positive indication of   
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Table 4. Summary of reported TdT heme phenotypes 
Gene, species Growth w/ 
heme1 
Restores heme 
utilization in E. 
coli hemA 
Binds 
heme2 
Ref. 
tdfG, Ng + NR NR [238] 
tdfH, Ng + - NR [238] 
znuD, Nm + + + [126] 
Ng, N. gonorrhoeae; Nm, N. meningitidis; NR, not reported 
1Isogenic mutants were tested for their growth with heme as the sole iron source.  
2Recombinant ZnuD was tested for its ability to bind hemin in vitro.  
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function as a heme receptor [27, 224]. TdfH was also thought to be one of the hemin 
affinity purified HmBPs, but failure of monoclonal antibody directed against the 97kDa 
HmBP  [134] to specifically detect TdfH, conclusively ruled out that possibility [238]. 
TdfJ, identified later as another gonococcal TdT [83], has been investigated for its 
contributions to heme utilization. Though uncharacterized in the gonococcus, the 
meningococcal TdfJ homologue, ZnuD was not required for growth in the presence of 
heme, but could restore heme utilization and growth when expressed in E. coli hemA 
[126].   
In light of inconsistent findings implicating TdfJ in heme acquisition, we revisited 
the contributions of TdfG, TdfH and TdfJ to gonococcal heme utilization. The studies 
presented herein address three main points in an attempt to resolve gaps in the 
literature with regards to the role of these TdTs in gonococcal heme utilization. First, we 
address the possibility that N. gonorrhoeae may express functionally redundant 
receptors for heme utilization. Since, the TdfJ homologue in N. meningitidis has an 
observable heme phenotype we generated double mutants unable to express TdfJ and 
TdfG or TdfH and assessed their ability to grow in the presence of heme. We expected 
that if these receptors contribute to heme utilization, double mutants would be defective 
for growth in limited heme conditions. Next, we restricted gonococcal growth to 
exogenous heme uptake in an attempt to maximize TonB-dependent heme uptake 
mechanisms and resolve the potential contribution of the aforementioned TdTs. To do 
this, we generated tonB and TdT mutants in a gonococcal heme auxotrophic 
background. We expected that growth under limited heme conditions would require 
TonB and TdT-dependent mechanisms. Finally, we address the possibility that TdfG, 
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TdfH, or TdfJ may facilitate the utilization of a “xeno-hemophore”. We identified a 
potential candidate hemophore and tested its ability to support gonococcal growth as 
the sole iron/ heme source. We expected that gonococcal growth in the presence of the 
hemophore would be indicative of the presence of a gonococcal hemophore receptor. 
This study thus presents a thorough examination of the roles of TdfG, TdfH and TdfJ in 
gonococcal heme utilization. 
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II. Results 
A. TonB and TdT double mutants are not defective for growth in limited 
heme conditions 
Since the meningococcal TdfJ homologue, ZnuD exhibited some positive 
indicators of a role in heme acquisition (see Table 4) we sought to evaluate the 
contribution of TdfG and TdfH to growth in heme limited conditions in double mutants 
unable to express TdfJ as well as TdfG or TdfH. Double mutants were made by first 
generating a construct, pVCU938, in which the tdfJ gene fragment was inactivated by a 
transposon encoding a Kan resistance cassette (Tn5<Kan-2>). This construct was then 
used to transform gonococcal strains FA1090 tdfG (MCV660) and FA1090 tdfH 
(MCV661) [83]. A schematic of the approach to mutant construction is presented Figure 
3. Kanamycin resistant (Kanr) gonococci were colony purified and subjected to a PCR 
screen for confirmation of the chromosomal mutation. In Figure 4, the genes tdfG, tdfH 
and tdfJ were PCR amplified with gene specific primers from DNA preparations of Kanr 
gonococcal transformants. The presence of a larger PCR product corresponding to the 
size of the insertion in gonococcal transformants compared to wild type is shown in 
Figure 4, confirming the successful generation of the tdfG tdfJ and tdfH tdfJ double 
mutants designated MCV935 and MCV936, respectively. 
To determine if TdfG, TdfH and TdfJ contribute to heme utilization, the growth of 
wild type, tonB and TdT isogenic and double mutant strains were evaluated in a liquid 
growth assay with limited heme as the sole iron source. We hypothesized that under 
these conditions, TonB and TdT-dependent mechanisms of heme utilization  
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Figure 3. Schematic of double mutant construction 
Diagram of strategy for double mutant construction. (A) The plasmid, pVCU938, which 
contains the gonococcal uptake sequence (GCU) as well as a fragment of tdfJ disrupted 
by Tn5<Kan-2> used to transform MCV660 (tdfG) and MCV661 (tdfH) is depicted. (B) 
Cartoon of homologous recombination event resulting in chromosomal integration of 
mutagenized tdfJ to generate double mutants. Genetic elements are not drawn to scale.   
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Figure 3. Schematic of double mutant construction 
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Figure 4. PCR screen of TdT double mutants. 
Boilate DNA preparations from Kanr MCV660 (tdfG) and MCV661 (tdfH) transformed 
with pVCU938 were PCR amplified with primers specific for tdfG, tdfH and tdfJ. PCR 
products were separated on a 1% agarose gel. (A) PCR screen of MCV935, tdfG tdfJ 
double mutant. Gene targets are listed above. Template DNA from the following strains 
were used for PCR: lane 1—wild type, FA1090; lane 2—MCV660 (tdfG); lane 3—
MCV661 (tdfH); lane 4—Kanr  MCV660 clone; lane 5—No template DNA. (B) PCR 
screen of MCV936, tdfH tdfJ double mutant. Template DNA from the following strains 
were used for PCR: lane 1—MCV660 (tdfG); lane 2—MCV661 (tdfH); lane 3—Kanr 
MCV661 clone 1;lane 4—Kanr  MCV661 clone 2; lane 5—No template DNA. 
 63 
 
A. 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
Figure 4. PCR screen of TdT double mutants. 
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would be observed by a growth defect in mutants lacking putative heme receptors. 
Gonococci were grown in partially chelexed GW media, a defined media permitting 
growth of gonococci from low inocula [251], in the presence of limited amounts of hemin 
and Desferal to chelate excess iron. Bacterial growth was measured via optical density 
(OD) readings every 2 hours for 8 hours, the results of which are presented in Figure 5. 
We found that tonB and TdT isogenic and double mutants were not defective for growth 
in heme limited conditions compared to wild-type strain FA1090 (Figure 5A). In fact, the 
tdfG isogenic and tdfG tdfJ double mutants grew significantly better than all of the 
strains tested. To ensure that optical density readings adequately represented any 
observable differences in growth, viable bacteria recovered from wild type and tonB 
after heme limited growth were enumerated. There was no significant difference in the 
amount of viable bacteria recovered indicating that TonB and the aforementioned TdTs 
do not contribute to gonococcal growth in these conditions (Figure 5B).            
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Figure 5. Heme-limited growth of tonB and TdT isogenic and double mutants. 
Gonococcal strains were grown in partially chelexed GW media supplemented with 
limited amounts of heme, 5µM. (A) Bacterial growth was measured via OD600 readings 
every 2 hours for 8 hours. Means and standard error of n=5 independent experiments 
are shown. (B) Viable bacteria recovered from wild type and tonB gonococci after 
growth for 8 hours in limited heme conditions were enumerated. Mean and standard 
error for n=4 independent experiments are shown. An un-paired Student’s t-test was 
used to determine significant differences in means; nd, no difference.    
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Figure 5. Heme-limited growth of tonB and TdT isogenic and double mutants. 
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B. Heme utilization in gonococcal heme auxotroph is TonB-independent 
Many bacterial pathogens that express heme receptors have incomplete heme 
biosynthetic pathways and are thus natural heme auxotrophs. As such, these 
pathogens require uptake of exogenous heme to support growth. N. gonorrhoeae has a 
complete heme biosynthetic pathway and does not require heme if it is provided 
exogenously along with an alternate iron source. It is possible that in the conditions of 
the previous assay, the gonococcal strains tested were not restricted to uptake of 
exogenous heme. To optimize the heme-dependent growth assay conditions and better 
resolve any TonB and/ or TdT-dependent heme utilization mechanisms, we generated a 
N. gonorrhoeae heme auxotroph as well as tonB and TdT mutants in this background 
and evaluated heme-dependent growth. We hypothesized that growth of the gonococcal 
heme auxotroph in limited heme conditions would require energy dependent uptake of 
exogenous heme and thus require TonB and a heme receptor. 
 To generate gonococcal heme auxotrophs, we obtained pUNCH1304, a 
construct in which gonococcal hemH is disrupted by a chloramphenicol 
acetyltransferase cassette, CAT [237]. The enzyme ferrochelatase, encoded by hemH, 
catalyzes the addition of iron to protoporphyrin IX to form protoheme. The hemH::CAT 
construct was then used to transform wild type, tonB, and TdT isogenic and double 
mutants. Chloramphenicol resistant (Cmr) gonococci were screened for chromosomal 
hemH mutation via PCR amplification with gene specific primers. As shown in Figure 6, 
a wild-type copy of hemH results in a PCR product of 1.3Kb. The mutant copy or 
insertionally inactivated hemH was detected in transformed gonococci as indicated by 
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PCR products of 2.3Kb, corresponding to the 1Kb CAT (Lanes 2, 7, 9-12). Table 5 lists 
all of the heme auxotrophic mutants generated.  
 The growth of wild type, hemH, and tonB hemH were evaluated in a liquid growth 
assay with limited heme. While both hemH and tonB hemH strains grew less well than 
wild type, there was no difference in growth observed between hemH and tonB hemH 
(Figure 7). These data indicate that TonB is not required for gonococcal growth 
restricted to exogenous heme uptake. Since heme uptake and subsequent growth was 
found to be TonB-independent in the gonococcal heme auxotrophic background, the 
remaining TdT hemH mutant strains were not further evaluated. 
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Figure 6. PCR screen of N. gonorrhoeae hemH mutants. 
Boilate DNA preparations from Cmr FA1090 (wild type) and MCV656 (tonB) gonococci 
transformed with pUNCH1304 (hemH::CAT) were PCR amplified with hemH specific 
primers. PCR products were separated on a 1% agarose gel. Lanes 1 and 6 contain 
DNA ladder. Lanes 2 and 3 are clones from Cmr FA1090. Lane 4 is a positive control 
with wild type template DNA. Lane 5 is a negative control with no template DNA. Lanes 
7-12 are clones from Cmr MCV656.  
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Figure 6. PCR screen of N. gonorrhoeae hemH mutants. 
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Table 5. N. gonorrhoeae heme auxotrophic mutants 
 
Strain Genotype 
PCR 
confirmation 
MCV937 tdfGΩ, tdfJ::Tn5, hemH::cat + 
MCV939 tdfJΩ, hemH::cat + 
MCV943 tdfGΩ, hemH::cat + 
MCV944 hemH::cat + 
MCV945 tdfHΩ, hemH::cat + 
MCV946 tonBΩ, hemH::cat + 
MCV947 ∆tbp, hemH::cat + 
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Figure 7. Heme-dependent growth of N. gonorrhoeae wild type and heme 
auxotrophic strains. 
Wild-type strain FA1090, hemH, and tonB hemH were grown in CDM supplemented 
with 5µM heme. Bacterial growth was measured via OD readings every 2 hours for 6 
hours. Means and standard error of a representative of n=3 independent experiments is 
shown. Differences in means at T=6 hours were determined by a Bonferroni Post-test in 
GraphPad Prism. P-values < 0.05 were considered significant and denoted with **.   
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Figure 7. Heme-dependent growth of N. gonorrhoeae wild type and heme 
auxotrophic strains.  
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C. N. gonorrhoeae cannot utilize P. gingivalis hemophore, HusA as a 
sole iron source 
The data reported thus far demonstrate that neither TonB nor TdfG, TdfH and 
TdfJ contribute to growth under limited heme conditions indicating that these TdTs are 
not free heme receptors. The possibility remains however that these TdTs may not 
function in uptake of free heme but rather assimilate heme from a heme-containing 
protein. N. gonorrhoeae has only been demonstrated to assimilate iron and heme from 
the host hemoprotein, Hg. It cannot utilize heme-Hx, serum albumin, myoglobin, or 
catalase as has been shown for other pathogenic bacteria [27, 65, 237]. However, 
another hemoprotein may be present within the context of infection: bacterial derived 
hemophores. The urogenital tract, the primary site of gonococcal infection, is rich in 
both normal and potentially harmful bacteria, which may produce proteins and 
metabolites facilitating iron/heme acquisition. Despite being unable to produce a 
siderophore [259], N. gonorrhoeae is capable of utilizing siderophores secreted by other 
bacteria [36, 98]. Similarly, N. gonorrhoeae may be able to utilize hemophores 
potentially secreted by bacteria within the same ecological niche.  
To identify potential candidate hemophores, we conducting a literature review to 
identify BV-associated bacteria with iron acquisition systems that N. gonorrhoeae could 
potentially hijack. Table 6 lists reported iron acquisition systems in BV-associated 
bacteria. Of the BV-associated bacteria considered, recent genome sequences 
revealed that Fusobacterium spp., Prevotella spp., and Porphyromonas gingivalis  
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Table 6. Iron acquisition and hemolytic genes in BV-associated bacteria 
BV-associated 
bacteria 
Normal 
site of 
infection 
Cytotoxin/ 
hemolysin 
Siderophore/ 
hemophore 
TonB-
dependent 
transporters 
(TdT) 
Ref. 
G. vaginalis 
UGT 
Vaginolysin,  
1 putative 
hemolysin 
siderophore 
biosynthesis 
genes 
 
NR [271] 
Fusobacterium spp. ORAL/ 
UGT 
NR NR 5 putative TdTs  [116] 
P. intermedia 17 
ORAL 
Several  
hemolysins 
NR 
8 putative heme 
TdTs 
[201, 275] 
P. bivia UGT NR NR NR [104] 
P. gingivalis 
ORAL/ 
UGT 
several 
gingipains 
HusA 
3 heme 
receptors 
5 additional 
putative TdT 
[77, 137] 
Sneathia amnii 
UGT 
2 putative 
hemolysins 
NR NR [93] 
UGT, urogenital tract; ORAL, oral cavity; NR, not reported 
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encode genes annotated as TonB-dependent transporters with putative or described 
functions in heme uptake [116, 170, 201]. Proteomic analysis of the outer membrane of 
Prevotella intermedia 17 also revealed the expression of TonB-dependent transporters 
involved in heme uptake in iron limited conditions [275]. Interestingly, the hmu locus of 
P.  gingivalis encoding the bipartite heme receptors HmuR/Y was also found in 
Prevotella intermedia 17. P. gingivalis and Prevotella spp. are within the Bacteroidetes 
phylum. A hemophore-like protein, HusA from P. gingivalis was recently identified [77]. 
This 21kDa protein was found to be both extracellular and cell-surface associated, 
demonstrated high affinity heme binding, and was required for heme utilization [77]. 
Given the relatedness of P. gingivalis and Prevotella spp., their expression of some 
homologous heme utilization systems, and their potential role in BV [180, 194, 275], the 
hemophore HusA was tested for its ability to support gonococcal growth as a sole 
iron/heme source.    
Recombinant HusA was expressed and purified from E.coli BL21 strain 
expressing pETR7, a pET24d (+) derivative expressing HusA minus the first 23 amino 
acid residues of a putative signal peptide sequence followed by a C-terminal His6-tag 
[77]. The purified recombinant protein at approx. 21kDa is shown in elution samples in 
Figure 8. To test the ability of HusA to support gonococcal growth, wild type, tonB, 
hemH, and tonB hemH strains were spread onto CDM plates supplemented with 
Desferal to chelate contaminating iron. Various iron sources were then added to wells 
bored into the solidified media. HusA, saturated with 50% heme, was one of the iron 
sources tested to support gonococcal growth. Control iron sources included apo bovine  
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Figure 8. Purified recombinant P. gingivalis hemophore, HusA. 
Samples collected during purification of recombinant P. gingivalis hemophore, HusA 
were separated on a 15% SDS-PAGE gel and Coomassie stained. Lanes are labeled 
as follows: M, molecular weight marker; FT, flow through; W1-2, wash samples; E1-5, 
elution samples; R, final rinse.     
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Figure 8. Purified recombinant P. gingivalis hemophore, HusA. 
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transferrin (apo-bTf), 30% saturated human transferrin (hTf), and free hemin. Plates 
were incubated overnight at 37°C with 5% CO2 and growth around each iron source 
was recorded. The growth of wild-type strain FA1090 around various iron sources is 
shown in Figure 9. As expected, apo-bTf did not support growth of wild type while 30% 
sat. hTf and free hemin in the presence or absence of excess Desferal all supported 
growth. HusA; however, at 50% heme saturation, was not able to supplement growth of 
wild-type N. gonorrhoeae or any of the strains tested. The growth phenotypes of tonB, 
hemH, and tonB hemH strains are listed in Table 7. As expected tonB did not grow 
when supplemented with apo-bTf or 30% saturated (sat.) hTf as utilization of hTf 
requires energy derived from TonB. The tonB mutant was still capable of heme 
utilization consistent with our findings and previous reports that gonococcal heme 
utilization is TonB-independent [19]. Also, the hemH and tonB hemH strains behaved as 
expected in that neither strain grew without heme supplementation despite the presence 
of an alternative iron source.   
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Figure 9. Growth of N. gonorrhoeae wild-type strain FA1090 with hemophore 
HusA and various iron sources. 
Gonococcal strains were spread onto CDM agarose plates supplemented with 10µM 
Desferal. Wells were bored into the solidified media and 20µL aliquots of various iron 
sources were placed into each well before incubation at 37°C with 5% CO2 overnight. 
Growth of wild-type strain, FA1090 is pictured. Iron sources, labeled 1-7 counter-
clockwise, are as follows: 1—7.5µM apo-bTf; 2—7.5µM 30% sat. hTf; 3—10µM hemin; 
4—10µM 50% sat. HusA; 5—10µM hemin + 10µM Desferal; 6—7.5µM 30% sat. hTf + 
10µM Desferal; 7—7.5µM 30% sat. hTf + 10µM hemin + 10µM Desferal.   
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Figure 9. Growth of N. gonorrhoeae wild-type strain FA1090 with hemophore 
HusA and various iron sources. 
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Table 7. Growth of N. gonorrhoeae strains with hemophore HusA and various iron 
sources 
Strain 
apo-
bTf 
30% 
sat. 
hTf 
10µM 
Heme 
50% 
sat. 
HusA 
10µM 
Heme 
+ DFO 
30% 
sat. hTf 
+ DFO 
30% sat. 
hTf + 10µM 
Heme + 
DFO 
FA1090, wild type - ++ + - + ++ ++ 
MCV656, tonB - - + - + - - 
MCV944 hemH - - + - + - + 
MCV946 tonB hemH - - + - + - + 
DFO, Desferal; +, growth; ++, robust growth; - , no growth; sat., saturated  
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III. Discussion 
Neisseria gonorrhoeae is quite adept at utilizing host derived proteins to entirely 
suffice for its nutritional requirement for iron. As such it encodes several TonB-
dependent receptors, four of which have been characterized to facilitate iron 
assimilation from host proteins Tf, Lf and Hg as well as bacteria derived siderophores 
[198]. In this study, we evaluated three uncharacterized gonococcal TdTs (TdfG, TdfH 
and TdfJ) for their role in heme utilization. While some evidence of their potential 
contribution to heme utilization has been reported (see Table 4), we re-examined them 
as candidate heme receptors by focusing on three aims not yet considered in the body 
of literature reported.  
First, we examined the possibility of redundant heme receptors and constructed 
double mutants unable to express TdfJ and TdfG or TdfH. When tonB as well as TdT 
isogenic and double TdT mutants where grown in limited heme conditions we found that 
neither TonB nor the TdTs alone or in combination contributed to growth (see Figure 5). 
We next considered the possibility that our system was not stringent enough to require 
gonococcal heme uptake and constructed gonococcal heme auxotrophs to require that 
growth was restricted to uptake of exogenous heme. While we expected heme uptake 
and growth of gonococcal heme auxotrophs in limited heme conditions to require 
energy, we found that TonB and by definition TdTs were not required (see Figure 7). 
These data lead us to conclude that under limited heme conditions, N. gonorrhoeae 
utilization of free heme occurs independently of TonB.  
It is possible that there are un-identified TonB systems which support gonococcal 
heme utilization despite lack of obvious gonococcal tonB paralogs in genome 
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annotations. Most bacteria with multiple TdTs for the uptake of various nutrients in 
different conditions encode more than one tonB paralog (anywhere from 2-9 have been 
reported) with partial redundancy and distinct specificity [48]. S. marcescens, for 
example, encodes six tonB paralogs [178]. HasB, a tonB paralog is encoded by the has 
operon and provides energy to the TdT HasR, to internalize free heme or heme from 
hemoproteins. Either TonB or HasB of S. marcescens can energize HasR, but HasB 
does so more efficiently [178]. Additionally, the structural diversity of tonB paralogs and 
limited sequence similarity may further obscure the presence of non-obvious tonB 
paralogs [59]. However, the observation that disruption of the one known TonB system 
is sufficient to abrogate transferrin, lactoferrin, and hemoglobin utilization [224] suggests 
that N. gonorrhoeae probably encodes a single TonB system, which is sufficient to 
support the function of all gonococcal TdTs. 
TonB-independent mechanisms of heme utilization have been dismissed as 
irrelevant because of the assumption that in the absence of energy, passive diffusion of 
nutrients across the outer membrane would require high heme concentrations, a 
scenario rare to mucosal environments where pathogenic Neisseria cause infection 
[209]. Our data suggest that even in very limited heme conditions, heme uptake occurs 
independently of TonB indicating that TonB-independent heme utilization may be 
physiologically relevant. As such, mechanisms of TonB-independent heme utilization 
may be of interest. Chen et al., reported that spontaneous mutants in PilQ increased the 
entry of heme, TX-100 and antibiotics as demonstrated by a hyper-sensitivity to heme 
and hydrophobic agents [44]. The effects of the pilQ mutations were decreased by loss 
of pilT, indicating that PilT helps to increase entry of small molecules through PilQ. PilQ 
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forms an exit pore for the assembled pilus fibril and PilT is responsible for twitching 
motility mediated by pilus retraction. Additionally, PilT is required for DNA transport into 
the cell and facilitates pilus degradation in the absence of PilQ [265]. As such, Chen et 
al., argued that entry of heme and hydrophobic agents may be mechanically linked to 
pilus retraction [44]. PilQ however cannot be the only mechanism of TonB-independent 
heme entry as strains lacking PilQ are still able to grow on free heme.   
Porins have been suggested as a non-specific heme entry mechanism [209]. 
However, lipophilicity in solute molecules has been shown to retard diffusion through 
the porin channel [174]. Additionally, heme tends to form hydrophobic aggregates which 
may be too large to diffuse through porins [133]. Diffusion of heme across the outer 
membrane may not require a protein channel, as the Neisseria outer membrane is 
generally highly susceptible to lipophilic agents [174]. This may be due to modification 
or masking of the phospholipid head groups as mutants with increased sensitivity to 
hydrophobic agents also demonstrated increased sensitivity to phospholipase C 
compared to wild type and mtr containing strains which were only sensitive to 
phospholipase C upon treatment with exoglycosidase [152]. The structure of neisserial 
LOS may also contribute to increased outer-membrane permeability to hydrophobic 
agents. LPS with short or no O-side chains was found to have increased fluidity 
compared to LPS with long O-side chains [174]. Additionally, faster lateral diffusion of 
an outer membrane protein was found in mutants unable to make LPS O-chain [174]. 
Increased membrane permeability to lipophilic molecules due to short O-side chains 
may also explain why heme uptake in Neisseria is TonB-independent, but TonB-
dependent and receptor mediated in other bacteria that would produce LPS with long O-
 86 
 
side chains and thus potentially have membranes less permeable to lipophilic 
molecules. In N. meningitidis, hyper-sensitivity to heme has been attributed to mutations 
in ght, named gene of hydrophobic agent tolerance [192]. The ght gene product was 
originally thought to be a periplasmic protein but recent studies have shown that Ght is 
an N-terminally anchored inner membrane protein with a cytoplasmic domain that 
interacts directly with LpxC to help regulate LPS biosynthesis [187]. Meningococcal 
studies have shown that mutations in ght result in decreased production of LPS and 
increased sensitivity to heme and other hydrophobic agents further supporting the role 
of LPS structure in outer-membrane permeability and potentially non-specific heme 
entry in Neisseria. Interestingly, attempts to construct ght mutant in N. gonorrhoeae 
have failed suggesting that ght is an essential gene in the gonococcus [192]  
Our studies also examined the possibility that the TdTs, TdfG TdfH and TdfJ 
were not receptors for free heme, but rather other hemoproteins. Besides Hg and Hg-
Hp complexes, pathogenic Neisseria cannot utilize other host derived hemoproteins like 
heme-Hx and heme-albumin as has been demonstrated for other heme receptors [65, 
209, 254]. The utilization of a bacterial derived hemophore is not inconsistent with 
Neisseria biology, as N. gonorrhoeae has been shown to be capable of utilizing 
siderophores synthesized by other bacteria [36, 98, 227]. As far as we are aware, this is 
the first study to examine the ability of N. gonorrhoeae to utilize a bacterial hemophore. 
We found that hemophore-like protein, HusA from P. gingivalis was not able to support 
gonococcal growth as the sole iron/heme source suggesting that N. gonorrhoeae does 
not encode a hemophore receptor for this protein. We hypothesized that HusA would be 
the best candidate hemophore to test since it may likely be encountered by N. 
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gonorrhoeae given its expression by P. gingivalis and the association of 
Porphyromonas and Prevotella species with BV, a known risk factor for gonococcal 
infection [263]. However, the hemophores described in the literature thus far (HusA, 
HasA-type, and HxuA) have no sequence similarity and demonstrate different 
mechanisms of heme coordination, and so it is also possible that Neisseria gonorrhoeae 
may be able to utilize another type of hemophore. The ability of HasA and HxuA to 
support gonococcal growth would need to be tested to conclusively state that N. 
gonorrhoeae does not encode a hemophore receptor. Since HxuA does not actually 
bind heme, but rather inactivates the biological function of Hx by inducing release of 
heme upon interacting with Hx [253], a gonococcal receptor for utilization of HxuA or 
HxuA-hemopexin is unlikely. The expression of the HasA-type hemophore in multiple 
bacteria may indicate an increased likelihood to be a ligand of any putative receptor-
mediated hemophore utilization in N. gonorrhoeae.  
These studies and others reported in the literature have attempted to identify 
additional TdTs contributing to heme utilization in Neisseria gonorrhoeae, but the lack of 
identification of novel specific mediators of gonococcal heme utilization despite reported 
and unreported efforts, may indicate that the currently described mechanisms of heme 
utilization represent the sum total of specific receptor-mediated strategies. Additionally, 
the collection of mutants in either pilQ, mtrCDE or ght demonstrating phenotypes of 
hyper-sensitivity further support findings that heme entry in Neisseria is non-specific [26, 
44, 192]. By demonstrating that in low heme conditions gonococcal heme utilization 
occurs independently of TonB even when exogenous heme uptake is required for 
growth and that N. gonorrhoeae cannot assimilate heme from a candidate hemophore, 
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our findings support the conclusion that heme utilization in Neisseria gonorrhoeae is 
non-specific and independent of TonB and TdTs.    
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Chapter 4: Regulation of gonococcal TdTs: TdfG TdfH and TdfJ 
 
 
I. Introduction 
In order to readily adapt to changing environments, bacteria regulate expression 
of genes that optimize growth in specific nutritional conditions. TonB-dependent 
transporters, as mediators of active uptake of essential nutrients that are either poorly 
permeable though porins or present at low concentrations, are highly regulated to 
optimize their expression in conditions where they are required. Regulation of the TdTs 
described thus far occurs at the transcriptional and post-transcriptional level through the 
activity of transcriptional regulators, riboswitches, and regulatory small RNAs (sRNAs) 
[175]. 
All TdTs that function in the transport of iron or iron-chelates are regulated by the 
transcriptional regulator, Fur. Fur, for ferric uptake regulator, generally acts as a 
repressor. In the presence of high intracellular levels of Fe2+, the Fur homodimer binds 
co-repressor Fe2+ and the holo-protein binds to a DNA sequence motif called the Fur 
box in the promoter of regulated genes thereby repressing their transcription. In low 
cellular Fe2+ levels, apo-Fur does not bind the Fur box, resulting in de-repression of 
regulated genes.  Other transcriptional regulators within the Fur family of 
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metalloregulatory proteins have also been shown to repress TonB-dependent 
transporters; for example NikR, for which Ni2+ acts as a co-repressor, represses the Ni 
transporter FrpB4 in Helicobacter pylori [205]. Additionally, Fur can indirectly regulate 
iron transport genes by regulating other types of regulators including two-component 
regulatory systems (TCS), AraC-like activators, and extra cytoplasmic function (ECF) 
sigma factors [87].             
      A sub-class of TonB-dependent transporters, termed transducers, function as 
both transporters and signal transducers that facilitate transcriptional activation of genes 
involved in transport of the TdT ligand. In addition to the plug and β-barrel domains of 
TonB-dependent transporters, these transducers are characterized by the presence of a 
unique N-terminal extension that functions as the signaling domain [122]. Perhaps the 
best characterized of these transducers is FecA, the TonB-dependent receptor for ferric 
citrate in E. coli K12. Signal transduction requires additional components; FecR, an 
inner membrane protein that functions as an anti-σ factor and FecI, an ECF σ factor that 
recruits RNA polymerase upon DNA binding to activate transcription [31]. Upon binding 
of the cognate ligand, ferric citrate, to the receptor FecA, conformational changes in 
FecA promote interaction of the N-terminal signaling domain of FecA with the 
periplasmic C-terminal end of FecR. The signal is transduced through the 
transmembrane segment of FecR to the N-terminal cytoplasmic end that activates FecI. 
FecI in turn binds to the promoter of the fecABCD operon and recruits RNA polymerase 
to induce transcription [29]. The FecI/R genes and the fecABCD operon are also 
Fe2+/Fur repressed so the fecABCD operon is doubly controlled guaranteeing rapid 
response to the cell’s iron status [31]. TonB-dependent transducers represent the 
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minority of TonB-dependent receptors; however, FecI/R type regulation has been 
identified in the homologous Fec systems of Klebsiella pneumoniae, Aerobacter 
aerogenes, and Shigella flexneri as well as heme and hemophore acquisition systems 
in Bordetella spp. and Serratia marcescens, respectively [30]. While the genomes of 
pseudomonads and Bacteriodes spp. are highly representative of transducer-type TdTs, 
genera of several important human pathogens including Hemophilus, Salmonella, and 
Neisseria seem to encode none [122].    
At the post transcriptional level some TdTs are regulated by riboswitches, RNA 
elements located at the 5’ end of mRNAs that change conformation upon ligand binding 
and modulate transcription or translation of the downstream gene(s) [175]. Expression 
of BtuB, the TdT for vitamin B12 (cobalamin) is controlled by a riboswitch at the 5’ end of 
the btuB mRNA. Vitamin B12 and adenosylcobalamin, a downstream product of vitamin 
B12 metabolism, bind to the riboswitch and induce the conformational change 
responsible for btuB repression [175]. The cobalamin and thiamine pyrophosphate 
responsive riboswitches may also regulate putative Co2+ and thiamine transport TdTs in 
addition to the vitamin B12 receptor [206].  
The small regulatory RNAs, OmrA and OmrB have also been shown to 
negatively regulate expression of TonB-dependent transporters: CirA, FecA, and FepA, 
the colicin I, ferric citrate, and ferric enterochelin receptors, respectively. The sRNAs, 
OmrA/B bind to the RNA chaperone, Hfq, which promotes RNA-RNA interactions [175]. 
OmrA/B are thought to repress CirA, FecA and FepA by directly base-pairing to early 
translation regions of the TdT mRNAs, this sRNA/mRNA binding inhibits translation and 
leads to subsequent degradation of the RNA complex [175]. OmrA/B are themselves 
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regulated by the TCS EnvZ/OmpR, osmolarity regulators further demonstrating a 
relationship between environmental conditions and TdT expression. OmrA/B are 
present in some other enterobacteria such as Salmonella, Klebsiella, and Yersinia spp. 
and while the regions of OmrA/B base pairing are conserved in cirA, the regulation of 
CirA or FecA and FepA by OmrA/B has not yet been demonstrated in the latter species 
[175].    
In pathogenic Neisseria, the TdTs that facilitate iron/iron-chelate utilization from 
transferrin (TbpA), lactoferrin (LbpA), hemoglobin/haptoglobin (HmbR and HpuB), and 
foreign siderophores (FetA) are all repressed by Fe/Fur [64, 106, 183]. Additionally, the 
TonB system and the fbpABC system, which transports ferric iron across the 
cytoplasmic membrane, are all Fe/Fur repressed. Neisseria spp. do not encode any 
TonB-dependent transducers and so do not display regulation by ECF σ-factors [122]. 
Recently, our laboratory reported that the bi-cistronic operon encoding the transferrin 
binding proteins TbpB and TbpA were found to be regulated by a long non-coding RNA 
located in the un-translated region upstream of tbpB [249]. In contrast to the described 
sRNAs, this RNA species is large at approximately 1.8Kb, does not overlap with the 5’ 
end of target gene tbpB and demonstrates limited regions of sequence complementarity 
[249]. This is the only instance of a putative regulatory RNA to regulate a neisserial TdT 
and so may represent a novel mechanism of TdT regulation in Neisseria; however, 
activity on other gonococcal genes and expression of this RNA species in N. 
meningitidis remains to be determined. In addition to Fur some neisserial TdTs have 
also been identified as targets in regulons of the two-component regulatory system 
(TCS) MisR/S and the AraC-like regulator, MpeR as well as the Fur family regulator 
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PerR/Zur. As such the reported activity of these transcriptional regulators in pathogenic 
Neisseria spp. is summarized below. 
The TCS, MisR/S is also referred to as PhoP/Q due to its homology to the 
PhoP/Q system of Salmonella and other enteric bacteria that regulate expression of 
virulence genes in response to Mg levels and pH [111]. Inactivation of PhoP/Q in other 
bacteria results in dramatic attenuation of virulence [164, 232]. Like other described 
TCS, MisR/S is comprised of a sensory histidine kinase, MisR, which is an inner 
membrane protein with periplasmic and cytosolic domains and response regulator, 
MisR, which is localized to the cytoplasm. Upon activation by an environmental 
stimulus, MisS undergoes auto-phosphorylation. MisS interacts with MisR via its 
cytoplasmic domain and activates MisR by transferring the phosphoryl group to MisR. 
The phosphorylation state of MisR modulates its DNA binding affinity resulting in 
differential regulation of target genes, which includes the misR/S operon itself 
demonstrating auto-induction [241]. Mutations of misR/phoP in N. meningitidis results in 
a variety of phenotypes including strain dependent sensitivity to Mg levels [111, 239] 
increased sensitivity to antimicrobial peptides and environmental conditions [111, 171-
172] as well as loss of PEA decorations from the inner core structure of LOS leading to 
the designation of MisR for meningococcal inner core structure [239]. Mutation of 
misR/phoP also resulted in increased sensitivity to mouse serum and reduced ability 
transverse a human epithelial cell monolayer [111] and attenuated virulence in the 
mouse model of infection indicating the role of this regulator in meningococcal virulence 
[171]. More recently, the MisR/S was found to be induced in contact with host cells and 
modulate genes involved in the adaptation of the bacterium to host cells suggesting that 
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the inducing signal for the system is host cell derived [107]. Two MisR/PhoP regulons 
have been described in N. meningitidis with approximately 30% overlap in regulated 
genes possibly due to difference in strains and growth conditions used [172, 240]. Both 
regulons identified TonB-dependent receptor TdfH as targets and TdfJ and HmbR were 
also each identified by one of the two studies [172, 240]. These data suggest that the 
MisR/S TCS may regulate some neisserial TdTs.     
The transcriptional regulator MpeR is an AraC-like regulator expressed 
specifically in pathogenic compared to be commensal Neisseria suggesting a potential 
role in virulence [155, 214]. More than 10,000 AraC homologs have been identified in 
protein databases throughout Gram-positive and Gram-negative bacteria thus 
representing one of the largest families of bacterial regulatory proteins [269]. Generally, 
AraC-like regulators have a conserved C-terminal DNA-binding domain and a variable 
N-terminal domain that is responsible for both protein dimerization and ligand binding. 
The paradigm for AraC-like regulators is the “light-switch” model of activation, wherein 
the dimeric regulator binds to distal operator sites of target genes resulting in DNA-
looping and repression of gene expression. Upon binding of the inducing ligand, the 
regulator undergoes allosteric change resulting in binding to proximal sites in the 
promoter of target genes resulting in opening of the DNA loop and transcriptional 
activation [269]. In Neisseria, MpeR is one of three AraC-like regulators [67]. MpeR is 
repressed by Fe/Fur and so can also act as a secondary regulator for indirect Fur 
activity [61, 64, 106].  The TdT, TdfF, which was found to be important for intracellular 
survival [83], is oriented in the opposite direction within the same genetic locus 
encoding MpeR. Thus, MpeR is hypothesized to regulate expression of TdfF [51], 
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although this has not been directly demonstrated. MpeR was however found to bind to 
the promoter of a putative iron related periplasmic binding protein (PBP) located 
upstream and in the same orientation of TdfF; thus its promoter is thought to drive the 
activity of the tdfF containing operon [67]. MpeR was also demonstrated to repress 
expression of MtrF, an inner membrane protein that enhances mtrCDE mediated 
induction of resistance to hydrophobic agents [71]. Additionally, MpeR was shown to 
activate FetA, the TdT that mediates utilization of catechol-like siderophores [36, 98]. 
Microarray studies of the MpeR regulon in N. gonorrhoeae revealed that TdfH was 
repressed late in the growth phase of mpeR mutant suggesting that TdfH is an MpeR 
target [161].                 
The Fur family transcriptional regulator, PerR was originally identified in N. 
gonorrhoeae as a peroxide sensing, Mn-dependent repressor that negatively regulates 
MntC, the PBP of the Mn-binding ABC transporter encoded by mntABC responsible for 
Mn-dependent resistance to oxidative stress [236, 268]. MntABC was later found to bind 
both Mn and Zn with equal affinity and PerR was concluded to behave like Zur, 
repressing target genes when bound to co-repressor Zn2+ in the presence of high 
intracellular Zn levels analogous to the Fe/Fur repression [135, 143]. Microarray studies 
of the PerR/Zur regulon in N. gonorrhoeae and the zinc responsive regulon of N. 
meningitidis share significant overlap identifying genes involved in Zn transport and 
maintenance of Zn homeostasis [181, 268]. Both regulons identified the TdTs TdfH and 
TdfJ as Zn/Zur targets [181, 268]. Interestingly, a gonococcal perR mutant 
demonstrated reduced invasion and intracellular survival in primary cervical epithelial 
cells [268] indicating that this regulator contributes to host cell interactions.  
 96 
 
 In the absence of described regulatory mechanisms beyond Fe/Fur described for 
neisserial TdTs, the transcriptional regulators MisR and MpeR represent the only other 
known modulators of TdT expression. Therefore, we sought to determine whether Fur, 
MisR and MpeR regulate the uncharacterized TdTs: TdfG, TdfH and TdfJ in N. 
gonorrhoeae. The identification of the regulatory networks to which these TdTs belong 
may reveal pertinent information about their function and contributions to the 
pathogenesis and fitness of N. gonorrhoeae in which little to no regulatory data on these 
TdTs has been reported. In addition to the aforementioned transcriptional regulators, we 
also assessed the expression of these TdTs in response to Zn and the Fur family Zn 
regulator, PerR/Zur. Together these studies present a comprehensive analysis of 
potential regulators of N. gonorrhoeae TdTs: TdfH TdfJ and TdfJ.   
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II. Results 
A. TdfG and TdfJ are Fur regulated 
To determine whether TdfG and TdfJ were regulated by Fur, we evaluated the 
expression of the gonococcal TdTs TdfG and TdfJ in a fur mutant. Wild type and fur 
mutant strains were grown in GC broth in the presence of Fe3+-specific chelator, 
Desferal to represent iron depleted conditions or in the presence of Fe(NO3)3 to 
represent iron replete conditions. Whole cell lysates standardized by culture density 
were analyzed via Western blot analysis with specific antiserum to detect TdfG and 
TdfJ. We found that TdfG expression was repressed in the presence of iron but 
elevated in iron depleted conditions in the wild type (Figure 10A) as has been previously 
reported [238]. There was no significant difference in TdfG levels detected in iron 
replete versus iron-depleted conditions in the fur mutant strain due to de-repression of 
TdfG in iron replete conditions (Figure 10A). These results indicate that the TdfG iron-
repression is Fur-mediated. Interestingly, there was still a trend of increased TdfG 
expression in iron depleted conditions in the fur mutant suggesting that other factors 
may contribute to TdfG expression in the absence of Fur. Overall TdfJ expression was 
reduced in the fur mutant compared to wild type. This difference was significant in iron 
depleted conditions indicating that Fur contributes to TdfJ activation in low iron 
conditions (Figure 10B). TdfJ expression is reported to be iron induced [64, 273]; 
however, densitometry analysis did not find significant differences in TdfJ levels 
detected in iron replete versus depleted conditions in either wild type or the fur mutant 
(Figure 10B).  
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Figure 10. Fur regulation of TdfG and TdfJ. 
Wild-type, FA1090 and fur mutant strains were grown for 2 hours in GC broth media 
treated with Desferal or Fe(NO3)3 to represent iron depleted or iron replete conditions, 
respectively. Whole cell lysates were standardized by culture density and analyzed via 
Western blot analysis. Densitometry was performed on a single immunoblot with three 
sets of replicate samples to determine arbitrary units (AU) of protein levels using NIH 
ImageJ. An un-paired Student’s t-test was used to compare means of protein levels 
detected. P-value < 0.05 was considered significant and denoted with *. (A) Left, a 
representative immunoblot probed for TdfG is shown. Right, densitometry results of 
TdfG levels detected (B) Left, a representative immunoblot probed for TdfJ is shown. 
Right, densitometry results of TdfJ levels detected. 
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B. TdfG is misR activated 
We next assessed the expression of TdfG, TdfH and TdfJ in wild-type strain 
FA1090 and the misR mutant to determine if MisR regulated any of these TdTs. 
Western blots of whole cell lysates from wild type and misR strains grown in iron replete 
and depleted conditions probed for each TdT are shown in Figure 11. Contrary to 
microarray studies identifying TdfH and TdfJ as MisR targets in N. meningitidis [172, 
240], we found that expression profiles of neither TdfH nor TdfJ were modulated in misR 
mutant strains compared to wild type (Figure 11A). Surprisingly, we found that TdfG 
levels were significantly reduced in the misR mutant in iron depleted conditions (P-value 
= 0.0130) suggesting that MisR activates TdfG expression (Figure 11B). Additionally, 
there was no difference in TdfG levels in the misR mutant grown in iron replete versus 
depleted conditions further indicating that MisR activation contributes to the iron 
regulation of TdfG (Figure 11B).  
C. MpeR does not regulate TdfG, TdfH or TdfJ 
TdfH was predicted to be an MpeR target in a gonococcal microarray study [161]. 
To determine if MpeR contributes to regulation of TdfH or any other TdTs, whole cell 
lysates from wild-type FA1090 and the mpeR mutant grown in iron replete and depleted 
conditions and analyzed via Western blot with specific antiserum. In Figure 12, we 
demonstrated that none of the TdTs had altered expression profiles in the mpeR mutant 
compared to wild-type strain FA1090.  
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Figure 11. MisR regulation of TdfG, TdfH and TdfJ.  
Wild-type, FA1090 and misR mutant strains were grown for 2 hours in GC broth media 
treated with Desferal or Fe(NO3)3 to represent iron depleted or iron replete conditions, 
respectively. Whole cell lysates were standardized by culture density and analyzed by 
Western blot with antisera against TdfG, TdfH or TdfJ as indicated. Densitometry was 
performed on a single immunoblot with three sets of replicate samples to determine 
arbitrary units (AU) of protein levels using NIH ImageJ. An un-paired Student’s t-test 
was used to compare means of protein levels detected. P-value < 0.05 was considered 
significant and denoted with *. (A) Left, representative immunoblot probed for TdfH is 
shown. Right, representative immunoblot probed for TdfJ is shown. (B) Top, a 
representative immunoblot probed for TdfG is shown. Bottom, densitometry results of 
TdfG levels detected. 
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Figure 11. MisR regulation of TdfG, TdfH and TdfJ.  
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Figure 12. MpeR regulation of TdfG, TdfH and TdfJ.  
Wild-type strain FA1090 and mpeR mutant were grown for 2 hours in GC broth media 
treated with Desferal or Fe(NO3)3 to represent iron depleted or iron replete conditions, 
respectively. Whole cell lysates were standardized by culture density and analyzed by 
Western blot with antisera against TdfG, TdfH or TdfJ as indicated. 
 
 
 
 
 
 
 
 
 104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. MpeR regulation of TdfG, TdfH and TdfJ.  
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D. TdfH and TdfJ are Zn repressed 
We did not observe any changes in TdfH expression in response to iron as has 
been previously reported [238]; thus, we sought to determine whether expression of 
TdfH and TdfJ were responsive to Zn levels since they are predicted to be targets of the 
Zn/Zur regulon in N. meningitidis and N. gonorrhoeae [181, 268]. Gonococcal wild-type 
strain FA1090 was grown in CDM in the presence of the zinc specific chelator, TPEN, 
ZnSO4 and/or Fe(NO3)3 at the indicated concentrations. We found that TdfH and TdfJ 
levels were repressed in presence of Zn (Figure 13). Conversely, expression of both 
proteins was up-regulated in the presence of increasing concentrations of TPEN. TdfH 
expression levels did not change in response to iron; however, TdfJ expression was 
further elevated when supplemented with iron, even at TPEN concentrations shown to 
de-repress TdfJ expression (Figure 13) suggesting that TdfJ is iron-induced and zinc 
repressed. To verify that TPEN treatment only altered Zn levels, we assessed 
expression of transferrin binding protein B (TbpB), which is known to be iron regulated. 
TbpB levels did not change at varying TPEN concentrations, indicating that TPEN 
treatment in these conditions is Zn specific.   
E. Zur mediates TdfH and TdfJ Zn repression 
To assess whether the observed zinc repression of TdfH and TdfJ was Zur-
mediated, we generated zur isogenic mutants by transforming gonococcal strains FA19 
and FA1090 with a zur::kan construct in which the zur gene is disrupted with a 
kanamycin resistance cassette. Kanr gonococci were selected and screened for 
chromosomal mutation via PCR with gene specific primers. In Figure 14 PCR products 
from Kanr gonococci show an increase in size corresponding to the size of the  
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Figure 13. Zn regulation of TdfH and TdfJ expression.  
Whole cell lysates standardized by culture density were analyzed by Western blot with 
antisera specific to TdfH, TdfJ or TbpB as indicated. Wild-type strain FA1090 was grown 
for 4 hours in CDM supplemented with Fe(NO3)3, ZnSO4 or Zn specific chelator, TPEN 
at the given concentrations.  
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Figure 13. Zn regulation of TdfH and TdfJ expression.  
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Figure 14. PCR screen of FA19 and FA1090 zur mutants. 
Boilate DNA preparations from Kanr FA1090 and FA19 gonococci transformed with 
zur::kan were PCR amplified with zur specific primers. PCR products were separated on 
a 1% agarose gel. (A) Lane 1—DNA ladder, lane 2—wild type template, lane 3—no 
DNA template, lanes 4-9—clones from Kanr FA19. Positive clones are denoted with an * 
and were designated MCV963. (B) Lane 1—DNA ladder, lane 2—wild type template, 
lane 3—no DNA template, lanes 4-10—clones from Kanr FA1090. Positive clones are 
denoted with * and were designated MCV964. 
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Figure 14. PCR screen of FA19 and FA1090 zur mutants. 
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kanamycin cassette confirming mutation. Zur mutants in FA19 and FA1090 background 
were designated MCV963 and MCV964, respectively. FA1090, FA19 and their 
respective zur mutant derivatives were then grown in GCB treated with ZnSO4 or TPEN 
to represent Zn replete or Zn depleted conditions, respectively and whole cell lysates 
were analyzed by Western blot. We found that expression of both TdfH and TdfJ was 
up-regulated under Zn depleted conditions in the wild type backgrounds and was 
significantly increased in zur mutant derivatives in both backgrounds (Figure 15). 
Additionally, TdfH and TdfJ were not differentially expressed under Zn replete versus Zn 
depleted conditions in zur mutants (Figure 15). These data indicate that Zn repression 
of TdfH and TdfJ is Zur mediated. We also observed that TdfH expression was 
noticeably higher in strain FA1090 compared to FA19 regardless of Zn levels while TdfJ 
expression was similar in both backgrounds (Figure 15). Interestingly, the increased 
TdfH expression in FA1090 versus FA19 was observed in the respective zur mutants. 
This suggests that the observed increase of TdfH expression in FA1090 occurs 
independently of Zur.    
F. TdfH is MisR activated in gonococcal strain FA19 
In an attempt to identify factors contributing to decreased TdfH expression in strain 
FA19, we re-examined the role of MisR in the FA19 background since the MisR 
regulatory network is distinct in different gonococcal strains (William M. Shafer, personal 
communication). We found that the misR mutant derivative in the FA1090 background 
showed no difference in TdfH expression compared to its parent when grown in Zn 
replete and Zn depleted conditions (Figure 16). By contrast, in FA19 the misR mutant 
derivative expressed less TdfH compared to its parent in both Zn replete and depleted 
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conditions (Figure 16). MisR was not found to alter the expression of TdfJ in either 
FA1090 or FA19. These data indicate that TdfH expression is controlled by additional 
players beyond Zn/Zur such as MisR, and that this regulatory pathway is distinct in 
different gonococcal strains. 
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Figure 15. Zur regulation of TdfH and TdfJ. 
Parental strains FA1090 and FA19 and respective zur mutant derivatives were grown in 
Zn replete and depleted conditions. Whole cell lysates standardized by culture density 
were analyzed by Western blot with antisera to TdfH or TdfJ as indicated.  
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Figure 15. Zur regulation of TdfH and TdfJ. 
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Figure 16. TdfH is MisR regulated in gonococcal strain FA19.  
Parental strains FA1090 and FA19 and respective misR mutant derivatives were grown 
under Zn replete and depleted conditions. Whole cell lysates standardized by culture 
density were analyzed by Western blot with antisera specific to TdfH or TdfJ as 
indicated. 
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Figure 16. TdfH is MisR regulated in gonococcal strain FA19. 
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III. Discussion 
In this study we analyzed the expression of TdTs TdfG, TdfH and TdfJ in 
response to Fe and Zn as well as transcriptional regulators Fur, MisR, MpeR and Zur. 
Given the abundance and at times conflicting reports of the TdTs expression in N. 
meningitidis and N. gonorrhoeae this study condenses the predicted regulators and 
examines their contribution to TdT regulation in N. gonorrhoeae to provide a 
comprehensive assessment of their expression and yield novel information about their 
potential function.  
Perhaps the least information is known about the gonococcal TdT, TdfG. It is the 
largest TdT in the neisserial genome, with an apparent molecular weight of 130kDa. 
Interestingly, it is absent in all meningococcal genomes as well as commensal Neisseria 
with the exception of N. elongata, the most ancestral of the Neisseria species evaluated 
in a comparative genomic study of commensal and pathogenic Neisseria [155]. This 
indicates that TdfG may represent a product of niche adaptation and be of particular 
importance for survival in the urogenital tract. TdfG was previously reported to be up-
regulated under conditions of iron limitation [64, 238] and the presence of a Fur box in 
the TdfG promotor was confirmed by Fur Titration Assay [106]. As such, we were not 
surprised to find that TdfG iron repression was Fur mediated. However, we were 
surprised to observe that TdfG expression was also MisR regulated specifically in iron 
limited conditions. MisR is not regulated by Fe/Fur indicating that the observed MisR 
activation occurs independently of Fur. This is the first report of an additional regulator 
modulating TdfG expression. Given the reported role of MisR/S in virulence and its 
potential role as regulator mediating adaptation to host cells [107, 171], the apparent 
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presence of TdfG in the MisR/S and Fur regulons may be indicative of a role in 
facilitating the utilization of a host-derived iron chelate. TdfG however, was not found to 
contribute to intracellular survival of N. gonorrhoeae in ME180 cervical epithelial cells 
[83]. Nonetheless, this novel finding in regards to TdfG expression represents an 
interesting development. Further studies to determine whether the observed MisR effect 
occurs directly or indirectly should be pursued.  
In stark contrast to TdfG, perhaps the most data, for an uncharacterized TdT has 
been reported for TdfJ, which is found throughout human Neisseria spp. TdfJ was 
reported to be up-regulated under iron replete conditions in N. gonorrhoeae [64, 273]. In 
the absence of TdfJ specific antibodies, changes in protein expression were not 
previously examined. However, our lab has found that TdfJ is indeed induced in the 
presence of iron [176]. We also report here for the first time in the gonococcus that TdfJ 
is Zn/Zur repressed. A Fur box was previously detected in the promoter of tdfJ 
(NGO1205) in N. gonorrhoeae and a mechanism of direct Fur-mediated activation has 
been proposed since iron induction of tdfJ transcript was not observed in a fur mutant 
and Fur was found to specifically interact with the tdfJ promoter [273]. However, a Zur 
box adjacent to and slightly overlapping the putative Fur box was also detected in the 
promoter of meningococcal homologue znuD [126, 225]. Zur specifically co-factored to 
Zn2+ was demonstrated to directly interact with the znuD promoter in N. meningitidis 
[181]. In N. meningitidis, znuD promoter activity was up-regulated in the presence of 
iron even in a zur mutant and Fur was also found to specifically interact with the znuD 
promoter [126]. Additionally, in the presence of both zinc and iron znuD promoter 
activity was repressed in wild type but induced in the zur mutant indicating that Zur 
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repression out competes the Fur-mediated activation when both Fur and Zur are 
expressed [126]. Together these data lead to proposed model whereby Fur binding can 
further augment ZnuD expression levels in zinc limiting conditions wherein znuD is 
already de-repressed. However, in zinc replete conditions, Zn/Zur binds to the Zur box 
and blocks Fe/Fur binding repressing znuD transcript and preventing Fur mediated 
activation in the presence of iron [126]. Our findings that TdfJ is both Fur activated and 
Zn/Zur repressed in the gonococcus support this model.  
It remains unclear why TdfJ would be simultaneously iron induced and zinc 
repressed. If TdfJ is in indeed a Zn transporter, it may be preferable to actively take in 
more Zn in high iron conditions to protect against the potential toxicity of high 
intracellular iron levels, although this would require simultaneously low Zn conditions to 
de-repress tdfJ. We did not observe any changes in TdfJ expression in the misR 
mutant, despite its identification as a MisR target in microarray studies [172] and its 
reported contribution to adhesion, invasion, and survival in A549, human lung epithelial, 
cells in N. meningitidis [126].  
In addition to TdfJ, we also report that in N. gonorrhoeae, TdfH is Zn/Zur 
repressed in support of microarray studies of zinc-responsive and Zur regulons in N. 
meningitidis and N. gonorrhoeae, respectively [181, 268]. We also report that while 
TdfH expression was unaffected by the presence of MisR in N. gonorrhoeae strain 
FA1090, it was reduced in the misR mutant in gonococcal strain FA19 indicating that 
TdfH is MisR activated in FA19 and differentially regulated in these two gonococcal 
strains. The overall increase in TdfH expression in strain FA1090 versus FA19 that 
remains evident in both zur and misR mutants suggest that other 
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factor(s)/mechanism(s) independent of Zur and MisR also contribute to the difference in 
TdfH levels detected between strains. This is the first study to report that TdfH 
expression is distinct in different gonococcal strains and may also be controlled by 
additional factors beyond transcriptional regulators Zur and MisR. 
We did not detect any changes in the expression of any of the TdTs tested in an 
mpeR mutant despite the report that tdfH transcript was reduced late in the log-growth 
phase of an mpeR mutant [161]. We should note that the expression studies reported 
here were conducted in the FA1090 background, while the MpeR regulon was reported 
for gonococcal strain FA19. This may be of significance since we detected dramatic 
changes in TdfH expression in the two backgrounds. As such, MpeR regulation should 
also be assessed in FA19.  
FA1090 and FA19 are both experimental strains of N. gonorrhoeae routinely 
used in the laboratory. FA1090 was isolated from the cervix of an individual with DGI, 
while FA19 was isolated from a patient with uncomplicated gonorrhea [113]. Distinct 
regulatory mechanisms have been previously reported in FA19 and FA1090. For 
example, MtrA, another AraC-like transcriptional activator that has been shown to 
activate expression of the multiple transferable resistance efflux pump (mtrCDE), is fully 
expressed in strain FA19 but contains an 11-bp deletion within the coding region in 
strain FA1090. Thus, FA19 but not FA1090 can induce expression of the Mtr efflux 
pump to induce resistance to hydrophobic agents [200]. In addition to activating 
mtrCDE, MtrA also represses MpeR [242]. It is possible that the misR effect in 
gonococcal strain FA19 reported here may be indirect as MisR/S, MpeR, and MtrA are 
connected in a regulatory network [161, 242], although MisR was found to directly 
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interact with the tdfH promoter in N. meningitidis [240]. Further investigation of the direct 
or indirect role of these regulators on TdfH expression will help to identify the novel 
players and/or the mechanism of any strain specific regulation. 
In previous studies, TdfH expression was detected in all meningococcal strains 
tested [226, 238] and 81% of gonococcal strains [238]. Of note, TdfH expression was 
not detected in any species of commensal Neisseria except for one out of six Neisseria 
lactamica strains [238] despite the presence of the gene in some commensal species 
[155].  In their comparison of genome sequences among human neisserial species, 
Marri et al. note that Neisseria lactamica has the most virulence associated alleles of all 
the commensals and can occasionally cause infection [155]. As previously noted, TdfH 
expression may be regulated by transcriptional regulator MpeR, which is found on a 
genetic locus specific to pathogenic Neisseria [155, 214].  It is possible that despite the 
presence of tdfH in select commensal species, its expression may be limited to 
pathogenic bacteria, in which TdfH expression can be activated. Thus, distinct 
regulatory profiles of TdfH may contribute to varying levels of virulence between strains.  
The data presented in this study resolves conflicting reports of regulation of 
TdfG, TdfH and TdfJ in N. gonorrhoeae. We report that TdfG is activated by MisR 
specifically in iron depleted conditions identifying for the first time a novel regulator of 
TdfG expression that may act independently of Fur. Additionally, we demonstrate for the 
first time in N. gonorrhoeae that both TdfH and TdfJ are Zn/Zur repressed implying roles 
in Zn acquisition in the gonococcus. Finally, we also report for the first time that TdfH is 
differentially regulated between gonococcal strains. We identify MisR to be an activator 
of TdfH in strain FA19, but also note that other factors contributing to strain-specific 
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TdfH expression may exist. Together these data presents new lines of investigation to 
pursue such as the contribution of TdfH and TdfJ to gonococcal Zn acquisition, which 
will be discussed in the following chapter.          
  
 122 
 
 
 
 
Chapter 5: Gonococcal TdT, TdfH, facilitates calprotectin utilization and 
contributes to survival in neutrophil extracellular traps 
 
 
I. Introduction 
Transition metals have many functional roles in crucial biological process that 
make them a necessary requirement for all living organisms. Zn, in particular, is an 
important catalytic and structural component of proteins. As such Zn-binding proteins 
are present in all kingdoms of life and represent approximately 8% of eukaryotic and 6% 
of archaeal and bacterial proteomes [7]. Zn containing proteins are involved in protein 
synthesis and degradation, DNA metabolism and repair, and neurotransmission [8]. The 
chemical properties of Zn, that are important for its biological activity also potentiate its 
toxicity, thus Zn homeostasis is tightly controlled across all domains of life.  
Bacteria require 1nM-10µM Zn for optimal growth [228]. To maintain Zn 
homeostasis, bacteria tightly regulate Zn transporters that facilitate Zn uptake and Zn 
efflux systems that mediate Zn tolerance. Zn acquisition in prokaryotes primarily occurs 
via an ABC transporter, ZnuABC. ZnuABC is comprised of PBP that exhibits high 
affinity Zn-binding, an inner membrane permease and an ATP binding domain that 
hydrolyzes ATP to provide the energy required to actively transport the substrate into 
the cytoplasm. ZnuABC systems are tightly regulated by Zur, a member of the Fur 
family of metal response regulators, which can sense sub-femtomolar concentrations of 
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cytosolic Zn [23]. In excess Zn conditions, the Zur dimer is associated with Zn and binds 
to a specific DNA motif, termed the Zur box, in the promotor of target genes and inhibits 
RNA polymerase binding and activity [23]. In low Zn conditions, Zn disassociates from 
Zur; apo-Zur has reduced affinity for the Zur box resulting in de-repression of the target 
genes. In addition to ZnuABC, low affinity Zn transporters such as ZupT in E. coli, which 
is homologous to eukaryotic ZIP family transporters, have also been described [88]. Zn 
can also enter bacteria non-specifically through broad specificity metal ion transporters 
such as MntH, which is a proton-dependent divalent cation importer and an Nramp 
(natural resistance-associated macrophage protein) homologue, as well as MgtA, a P-
type ATPase that may transport Zn as well as Mg. Both MntH and MgtA have been 
identified in Salmonella typhimiruim and E. coli [23]. In conditions of excess Zn, Zn-
efflux systems such as ZntA of E. coli facilitate energy dependent efflux of Zn2+ and 
Cd2+ from the cytosol to mediate Zn tolerance [23, 86].  
Under normal physiological conditions, serum Zn levels are reported to be about 
13-20µM and is probably sufficient to support microbial growth [228]. However, the 
reduction of serum Zn levels along with the concomitant increase of Zn binding proteins 
and Zn uptake in the liver in association with infectious and non-infectious disease has 
long been noted [228]. More recently, a variety of mechanisms for host-mediated Zn 
limitation have been described. In a mouse model of acute inflammation and infection, 
LPS treated mice developed hypozincemia, which was mediated by a cytokine 
(primarily IL-6) signaling cascade that stimulates increased synthesis of metallothioein, 
a host Zn storage protein, and liver specific Zn importer, ZIP14 [148]. The host strategy 
of limiting essential nutrients from invading pathogens has been designated “nutritional 
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immunity”. While traditionally characterized as the sequestration of iron from pathogens, 
roles for other transition metals such as zinc and manganese are now being examined 
[101, 117, 257]. The host protein calprotectin has been identified as a key mediator of 
nutritional immunity at sites of infection.  
Calprotectin (CP) is a heterodimeric protein complex comprised of S100A8/A9, 
members of the calgranulin subgroup of the S100 family proteins, which are low 
molecular weight (10-14kDa) and characterized by two EF- hand calcium-binding 
domains separated by a hinge region. These proteins are expressed in monocytes, and 
can be induced in epithelial cells, endothelial cells, keratinocytes and activated 
macrophages [102, 276]. Members of the calgranulin super family including S100A7 
and S100A12 in addition to S100A8 and S100A9 have been implicated in inflammatory 
diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and 
cancer because of their immuno-modulatory roles that lead to overly active immune 
responses and pro-tumor environments [78, 102, 182, 276]. S100A8 and S100A9 have 
the highest expression in neutrophils where they represent 40-60% of neutrophil 
cytosolic proteins. All of the S100 family proteins form homodimers; S100A8 and 
S100A9 preferentially form heterodimers. The S100A8/S100A9 heterodimeric complex 
is called calprotectin because of its antimicrobial activity attributed to its ability to chelate 
transitions metals Zn and Mn [49, 216].  Higher order oligomers, which are responsible 
for some biological activities, can also form in a calcium-dependent manner [136].    
Calprotectin has two transition metal ion binding sites along the dimer interface. 
One site (Site I) binds both Zn and Mn at high affinity, while the other (Site II) only binds 
Zn at high affinity [58]. Calcium binding increases the affinity of Zn-binding sites [34]. 
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Given the calcium ion gradient across the plasma membrane, calcium is thought to act 
a molecular switch for Zn-chelating activity whereby cytoplasmic CP primarily exists in a 
lower Zn affinity form, extracellular CP is predominately calcium bound and thus adopts 
a higher Zn affinity form [34]. CP may also act as an intracellular calcium sensor since 
conformational changes that occur as a result of calcium binding during calcium 
signaling cascades can modulate calprotectin’s interaction with target proteins [276].  
CP can be secreted into the extracellular environment actively via intact 
microtubule networks or released by activated neutrophils during neutrophil extracellular 
trap (NET) formation or cell necrosis [276]. CP concentrations can reach >500µg/mL at 
sites of infection [110]. In vivo, CP accumulates in tissue abscesses upon neutrophil 
influx and has been shown to have potent anti-microbial activity against Staphylococcus 
aureus [49], Candida albicans [243], Klebesiella pneumonia [1], Acinetobacter 
baumannii [100] and Helicobacter pylori [76]. In vitro, the recombinant protein also has 
antimicrobial activity against a wide number of pathogens including: Candida albicans 
[215], Aspergillus fumigatus [3], P. aeruginosa [57], Staphylococcus epidermis, 
Staphylococcus lugdunensis, Enterococcus faecalis, E.coli, and S. flexneri [58], which is 
reversed upon zinc supplementation. Given the effective host strategy of Zn limitation, 
microbial Zn acquisition systems have been shown to be important for pathogenesis. Zn 
uptake systems in C. jejuni, Salmonella enterica, H. ducreyi, uropathogenic E. coli, 
Brucella abortus, and Streptococcus pyogenes are required for virulence or colonization 
[117].       
Pathogenic Neisseria encode the ZnuABC system with homology to the E. coli 
ZnuABC system for Zn accumulation [46, 225]. Interestingly, ZnuABC, which has also 
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been reported as MntABC, binds both Zn and Mn at equimolar affinities; other bacteria 
maintain separate systems with unique binding affinities for each metal [143, 236]. ZupT 
was also identified in N. meningitidis as a Fe/Fur repressed gene but is absent in N. 
gonorrhoeae [61].  PerR, also known as Zur, is a Fur homolog that represses 
Zn/MntABC in the presence of Zn [143, 268]. Microarray analysis of the PerR/Zur 
regulon in both N. meningitidis and N. gonorrhoeae revealed that two TonB-dependent 
transporters: TdfH and TdfJ were PerR/Zur regulated, suggestive of their roles in Zn 
acquisition [181, 268]. In N. meningitidis, the TdfJ homologue, ZnuD, was identified as 
the first bacterial outer membrane transporter to facilitate Zn acquisition as it was found 
to contribute to meningococcal growth in low Zn conditions [225]. More recently, CbpA, 
the TdfH homologue, was found to facilitate meningococcal growth in presence of CP in 
a TonB-dependent manner [226]. The functions of the meningococcal homologues of 
ZnuD and CbpA have not been tested in N. gonorrhoeae.    
In the following studies we examine the role of TonB-dependent transporters, 
TdfH and TdfJ in Zn acquisition and CP utilization in N. gonorrhoeae. We also examined 
the ability of TdfH and TdfJ to bind CP specifically in the context of whole gonococcal 
cells. The studies described herein go further to evaluate the contributions of these 
TdTs to Zn accumulation in the presence and absence of CP. Additionally, we 
evaluated the contribution of TdfH to gonococcal survival in neutrophil extracellular 
traps (NETs). Together with the data reported for N. meningitidis, the results presented 
in this study characterize the function of these TdTs in pathogenic Neisseria and report 
for the first time the contribution of TdfH to N. gonorrhoeae survival in NETs.     
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II. Results 
A. TdfH, TdfJ and TonB contribute to growth under Zn restricted 
conditions  
Given the regulation of these TonB-dependent receptors by Zn/Zur reported in 
Chapter 4, we sought to determine whether these receptors contribute to gonococcal Zn 
acquisition. We hypothesized that those gonococcal strains lacking a Zn receptor would 
be deficient for growth under Zn restricted conditions. Likewise, we expected that upon 
supplementation with Zn, growth of wild-type gonococci would recover, whereas strains 
lacking receptors contributing to Zn utilization would remain suppressed for growth. To 
test this hypothesis, wild type, tdfH, tdfJ, and tonB mutant strains (FA19, MCV927, 
MCV928 and MCV650) [227] were grown in GCB treated with Zn-specific chelator, 
TPEN in the presence or absence of additional Zn. After growth for 6 hours viable 
bacteria were enumerated. As expected, fewer viable wild-type bacteria were recovered 
when grown in Zn restricted compared to Zn replete conditions (Figure 17). We found 
that significantly fewer viable bacteria were recovered from the tdfH mutant than wild 
type after growth in the presence of Zn. Additionally, there was no difference in the 
number of bacteria recovered from the tdfH mutant grown with or without Zn, consistent 
with a function for TdfH in Zn acquisition. The tdfJ mutant was the most impaired for 
growth in Zn replete or depleted conditions; however, growth was partially restored by 
addition of Zn. These data suggest that TdfJ is important for growth under Zn restriction 
but also imply additional mechanisms of Zn acquisition in the absence of TdfJ 
expression. Significantly fewer bacteria were also recovered from the tonB mutant  
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Figure 17. Gonococcal growth in Zn replete and Zn restricted conditions. 
Wild type (FA19), tdfH (MCV927), tdfJ (MCV928) and tonB (MCV650) gonococcal 
strains were grown in GCB treated with Kellogg’s Supplement I, 12μM Fe(NO3)3 and 
12.5μM TPEN in the presence or absence of ZnSO4 (18.75μM) for 6 hours before being 
serial diluted and spot plated on GCB-VCN plates for CFU determination. Mean and 
standard error from a representative of n=3 independent experiments are plotted above. 
An un-paired Student’s t-test was used to determine significance. *, P ≤ 0.05; **, P ≤ 
0.005, n.d., no difference. 
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Figure 17. Gonococcal growth in Zn replete and Zn restricted conditions. 
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than wild type, indicating that TonB also contributes to growth under Zn restricted 
conditions. 
B. TdfH is required for growth in the presence of calprotectin 
Since both tdfH and tdfJ were found to contribute to growth under Zn restricted 
conditions, we tested the possibility that these transporters may be required for the 
assimilation of Zn from host derived Zn-binding protein, calprotectin (CP). CP is a 
hetero-oligomeric protein complex that constitutes 45% of the cytosolic protein content 
of neutrophils [94]. It has been demonstrated to have antimicrobial activity against a 
wide range of pathogens, which has been attributed to its Zn2+ and Mn2+ chelating ability 
[49, 216].  We therefore tested the ability of wild type, tdfH and tdfJ mutant strains to 
grow in the presence of CP supplemented with Zn under Zn restricted conditions. 
Contrary to the antimicrobial activity reported against other pathogens [49, 58], we 
found that the growth of wild-type gonococci was enhanced in the presence of Zn –
laden CP (Figure 18). Addition of CP also specifically suppressed growth of the tdfH 
mutant, as growth of the tdfJ mutant was similar to that of wild type. These data suggest 
that N. gonorrhoeae is capable of overcoming the antimicrobial effects of CP via a 
mechanism that requires TdfH. To confirm that TdfH was indeed responsible for the 
observed CP resistance, we generated a complemented derivative of the tdfH mutant 
strain, MCV956 (tdfHC). Expression of TdfH upon treatment with IPTG was confirmed 
(Figure 19). Growth in the presence of CP was restored in tdfHC (Figure 20A), 
demonstrating that growth in the presence of CP specifically requires TdfH expression. 
Additionally, the tdfH growth defect was specific to CP treatment as neither tdfH nor  
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Figure 18. tdfH is defective for growth in the presence of CP 
Gonococcal strains were grown under Zn-limited conditions (CDM, 1μM TPEN). Some 
cultures were further supplemented with a CP + Zn mixture (10μM CP, 5μM ZnSO4). 
Growth was monitored by OD600 readings every 2 hours for 6 hours. Plotted are the 
mean and standard error of the mean of n=2 independent experiments. 
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Figure 18. tdfH is defective for growth in the presence of CP 
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Figure 19. Expression of TdfH in complimented derivative strain, MCV956 (tdfHC) 
Gonococcal strains FA19, MCV927 (tdfH), and MCV956 (tdfHC) were grown in CDM 
supplemented with 24μM Fe(NO3)3 +/- 2mM IPTG. Whole cell lysates standardized by 
culture density were subjected to SDS-PAGE analysis followed by immunoblotting with 
antiserum specific to TdfH. 
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Figure 19. Expression of TdfH in complimented derivative strain, MCV956 (tdfHC) 
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Figure 20. Growth in the presence of CP is restored in MCV956 (tdfHC).  
Gonococcal strains were grown under Zn-limited conditions (CDM, 1μM TPEN). (A) 
Cultures were supplemented with a CP + Zn mixture (10μM CP, 5μM ZnSO4) (B) 
Cultures were supplemented 5μM Zn alone or not further treated. Growth was 
monitored by OD600 readings every 2 hours for 8 hours. Plotted are the mean and 
standard error of the mean of n=3 independent experiments. 
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Figure 20. Growth in the presence of CP is restored in MCV956 (tdfHC).  
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tdfHC were more defective for growth compared to wild type when supplemented with 
Zn alone (Figure 20B). 
C. TdfH enables binding of CP by N. gonorrhoeae 
Given the ability of N. gonorrhoeae to grow in the presence of CP, we next 
sought to determine whether gonococci were capable of CP binding at the cell surface. 
Whole gonococcal cells, grown in CDM with Fe(NO3)3 and TPEN, were applied to 
nitrocellulose paper, presenting cell surface proteins in their native conformation within 
an intact bacterial outer membrane. After blocking, membranes were incubated with Zn-
laden CP, before being washed and probed for CP. CP was specifically detected 
associated with wild-type gonococci indicating that N. gonorrhoeae is indeed capable of 
binding CP (Figure 21A). Additionally, CP binding was reduced by 80% in both tdfH 
isogenic and tdfH tdfJ double mutants in FA1090 indicating that TdfH mediates the 
gonococcal/CP interaction. CP binding by wild-type strain FA19 was much reduced 
compared to FA1090 consistent with our previous findings that less TdfH was detected 
in whole cell lysates of strain FA19 compared to FA1090 (see Figure 15). However, CP 
binding was restored in tdfHC upon IPTG induction (Figure 21B) demonstrating that 
TdfH specifically facilitates the gonococcal/CP interaction in both FA1090 and FA19. 
D. TdfH and TonB are important for Zn accumulation in N. gonorrhoeae 
We suspected that TdfH, as a TonB-dependent transporter, and TonB would 
contribute to Zn internalization. To test this, we grew wild type, tdfH and tonB mutants 
under Zn replete and depleted conditions and assessed the level of internalized Zn 
using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). All of the  
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Figure 21. CP binding to gonococcal whole cells.  
Gonococcal strains were grown in CDM supplemented with 24μM Fe(NO3)3 for 4 hours 
before equal culture densities of bacteria were applied to nitrocellulose paper. 
Membranes were first blocked before incubation with CP. After washing, blots were then 
subjected to immunoblotting using CP specific antiserum. Densitometry was performed 
on replicate blots using NIH ImageJ. Signal intensities were normalized to that of wild 
type and expressed as % CP binding. A paired Student’s t-test was used to compare % 
CP binding; P ≤ 0.05 was considered significant and is designated by an *. (A)  A 
representative dot blot with gonococcal strains FA1090 (wild type), MCV661 (tdfH), 
MCV662 (tdfJ), MCV936 (tdfH tdfJ) applied to nitrocellulose before CP incubation and 
detection. Below, densitometry results of n=3 replicate blots are shown. (B) A 
representative dot blot with gonococcal strains FA19 (Wild type), MCV927 (tdfH), and 
MCV956 (tdfHC) applied to nitrocellulose. TdfH expression in tdfHC was un-induced (UI) 
or induced (I) by the addition of IPTG (2mM). Densitometry results of n=3 replicate blots 
are shown below the dot blot. 
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Figure 21. CP binding to gonococcal whole cells.  
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gonococcal strains tested accumulated significantly more Zn when grown under Zn 
replete versus Zn-depleted conditions (P-value < 0.05) indicating that the growth 
conditions adequately represented Zn replete and depleted conditions (Figure 22). 
Additionally, we found that tdfH and tonB mutants internalized significantly less Zn when 
grown in both Zn replete and depleted conditions compared to wild type (P-value < 
0.05). These data suggest that TdfH and TonB contribute to Zn accumulation. 
Given the demonstrated interaction between TdfH and CP and the role of TdfH 
and TonB in Zn accumulation (Figure 22A), we determined whether TdfH contributed to 
Zn accumulation in the presence of CP. Wild type and tdfH mutants where grown under 
Zn depleted conditions in the presence of Zn-laden CP and the levels of internal Zn was 
assessed via ICP-OES. We found that the tdfH mutant accumulated less Zn than wild 
type in the presence of CP (Figure 22B). These data indicate that TdfH facilitates Zn 
assimilation from CP.  
E. TdfH contributes to gonococcal NET survival 
Gonococcal infection is characterized by a robust recruitment of neutrophils, 
which migrate to the site of infection and attempt to eliminate the invading microbes via 
phagocytosis and/or NET formation [165]. As a major component of neutrophil cytosolic 
proteins, CP is released during NET formation and remains associated with NETs 
where it has been demonstrated to be the active component in NET-mediated killing of 
Candida albicans [243]. Thus, we sought to determine if gonococcal CP utilization, as 
mediated by TdfH, conferred a bacterial survival advantage in the presence of NETs. 
Gonococcal opacity proteins (Opa), which are subject to phase and antigenic variation,   
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Figure 22. TdfH and TonB contribute to gonococcal Zn accumulation.  
Gonococcal strains were grown in Zn replete or depleted media before bacterial cells 
were harvested and analyzed for metal levels via ICP-OES. Means and standard error 
from a representative of n=3 independent experiments are plotted. An un-paired 
Student’s t-test was used to determine significance. *P ≤ 0.05, **P ≤ 0.005. Trends in 
statistical significance were consistent between biological replicates. (A) Strains FA19 
(WT), MCV927 (tdfH), and MCV650 (tonB) were analyzed for Zn levels. (B) Strains 
FA19 and MCV927 (tdfH) were grown in Zn depleted media supplemented with CP + Zn 
(2μM CP, 1μM Zn) before bacterial cells were harvested for metal analysis via ICP-
OES. Means and standard error from a representative of n=3 independent experiments 
are plotted.   
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Figure 22. TdfH and TonB contribute to gonococcal Zn accumulation.  
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have been shown to differentially stimulate and survive exposure to neutrophils [12]. To 
eliminate this variability, we constructed a tdfH mutant (MCV955) in the FA1090 
Opaless background (Figure 23), and assessed its survival in NETs compared to the 
Opaless parent.   
Primary human neutrophils were treated with phorbol myristate acetate (PMA) to 
activate neutrophils and stimulate NET formation [33]. Activated neutrophils were then 
treated with cytochalasin D to inhibit phagocytosis and select for only extracellular 
mechanisms of neutrophil killing. DNase I was added to some NETs to assess the role 
of intact DNA fibers on NET-mediated killing. Neutrophils were then infected with the 
Opaless parent, MCV955 (tdfH) or Δnuc. The Δnuc strain was used as a positive control 
for DNase I-reversible sensitivity to NET-mediated killing [115]. We found that while the 
Opaless parental strain demonstrated little to no survival defect in the presence of NETs 
with or without DNase I, only 40% of the tdfH mutant survived exposure to neutrophils 
producing NETs (Figure 24).  Additionally, we found that treatment with DNase I 
significantly increased survival of the tdfH mutant indicating that intact DNA fibers 
contribute to the observed NET sensitivity of the tdfH mutant. These results 
demonstrate that TdfH is important for gonococcal resistance to NET-mediated killing. 
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Figure 23. Confirmation of tdfH mutant in FA1090 Opaless background. 
Gonococcal strains Opaless parent, MCV661 (tdfH) and MCV955 (Opaless tdfH) were 
grown in CDM supplemented with 24μM Fe(NO3)3. Whole cell lysates standardized by 
culture density were subjected to SDS-PAGE analysis followed by immunoblotting with 
antiserum specific to TdfH. 
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Figure 23. Confirmation of tdfH mutant in FA1090 Opaless background. 
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Figure 24. TdfH enhances bacterial survival in NETs. 
Human neutrophils were stimulated to induce NET formation and infected with Opaless, 
MCV955 (tdfH) or Δnuc at an MOI= 1 in the presence of Cytochalasin D +/- DNase I for 
1 hour. Bacterial survival is expressed as percentage of initial inocula. Mean and 
standard error of n=6 independent experiments are shown. Significance was 
determined by an un-paired Student’s t-test. *, P-value < 0.05; **, P-value ≤ 0.005. 
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Figure 24. TdfH enhances bacterial survival in NETs. 
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III. Discussion 
The data presented in these studies demonstrate that N. gonorrhoeae can resist 
the host derived Zn-chelating immune effector protein CP. We find that CP resistance is 
mediated by the TdT, TdfH, which facilitates CP binding and growth in the presence of 
CP. These data demonstrate for the first time that N. gonorrhoeae deploys an additional 
strategy to evade nutritional immunity by TdT-dependent utilization of the host nutrient 
binding protein, in this case CP.  While TdfH was originally suggested to contribute to 
heme acquisition due to its similarity to heme receptors, previous studies found that 
TdfH was not able to restore heme utilization in an E. coli hemA mutant [238] nor was it 
required for gonococcal growth in the presence of heme. The data reported here 
demonstrate that gonococcal TdfH is instead a receptor for CP as we have found that it 
is required for gonococcal binding of CP and is required for growth in the presence of 
CP. These findings are consistent with the report that CbpA, the meningococcal TdfH 
homologue, is required for growth of N. meningitidis in the presence of CP and for CP 
binding [226]. The current report goes further to demonstrate that TdfH facilitates Zn 
accumulation both in the presence and absence of CP in N. gonorrhoeae in support of 
the model that TdfH facilitates utilization of Zn from CP to overcome its antimicrobial 
effects.      
CP has largely been described as having inhibitory activity on the growth of 
numerous microbial pathogens [49, 58, 276]. Bacterial Zn acquisition systems in 
Aspergillus fumigatus [3], Acinetobacter baumannii [100], Pseudomonas aeruginosa 
[57] and Salmonella typhimurium [145] have been reported to facilitate resistance to CP. 
Specifically in Gram-negative bacteria, the bacterial factors contributing to CP 
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resistance have been limited to the high affinity zinc uptake system, ZnuABC [57, 100, 
145]. The report that meningococcal CbpA, binds to CP [226] and our findings that the 
gonococcal homologue, TdfH not only binds CP but is also required for Zn accumulation 
from CP identifies an outer membrane receptor that can directly interact with CP to 
overcome CP mediated Zn sequestration.  
At the mucosal epithelia, neutrophils are the first line of defense, localizing to the 
site of infection and killing invading microbes by phagocytosis and subsequent 
degranulation or via NET formation. Neisseria gonorrhoeae can survive neutrophil influx 
through a variety of mechanisms including arresting maturation of phagosomes 
containing gonococci, suppressing oxidative burst, and expression of a nuclease in 
NETs [55, 112, 115]. 
NETs are mainly comprised of DNA, histones as well as neutrophil granule and 
cytosolic proteins. CP has been detected as major component of NETs [243]. NET-
mediated killing is thought to occur by ‘trapping’ of microbes by chromatin fibers and 
high levels of antimicrobial proteins and molecules like CP and cathepsin G in the 
micro-environment of the traps [33]. DNase treatment degrades NETs and destroys the 
NET micro-environment and can thus abrogate NET-mediated killing as has been 
shown for other bacteria [33]. CP, through its Zn-chelating activity, was found to be the 
major antimicrobial component in NETs against Candida albicans, Klebsiella 
pneumoniae, and Aspergillus nidulans [1, 17, 243]. DNA was also found to have 
antimicrobial activity though metal chelation in NETs [85]. As such, a mechanism to out-
compete or overcome host nutrient sequestration strategies would provide a significant 
survival advantage. Indeed in N. meningitidis, the Zn-outer membrane transporter, 
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ZnuD was found to contribute to survival within NETs [129]. While we did not evaluate 
the contribution of gonococcal ZnuD homologue, TdfJ to NET survival, the data reported 
in this study demonstrate for the first time that TdfH facilitates gonococcal resistance to 
CP and that TdfH expression contributes to survival in NETs. CP has been shown to be 
the key antimicrobial component of NETs; thus, these findings represent a novel 
gonococcal neutrophil resistance strategy wherein TdfH assimilates Zn from CP, 
neutralizing its antimicrobial activity, to contribute to survival in NETs.  
We also report that TdfJ contributes to Zn acquisition in N. gonorrhoeae as fewer 
viable bacteria were recovered from the tdfJ mutant compared to wild type when grown 
in Zn replete and depleted conditions. The meningococcal TdfJ homologue, ZnuD was 
previously reported to have functions in both Zn and heme acquisition [126, 225]. 
However, our findings, reported in Chapter 3, did not support a role for TdfJ or any other 
TdT in gonococcal heme acquisition. ZnuD was also reported to contribute to 
adherence, invasion and intracellular survival of N. meningitidis in lung epithelial cells 
[126]. Previous studies from our laboratory have found that TdfJ does not contribute to 
invasion or intracellular survival of N. gonorrhoeae in cervical epithelial cells [83, 176]. 
Thus, it appears that while sharing 96% identity with TdfJ, meningococcal ZnuD has 
additional functions beyond Zn acquisition that are not observed in N. gonorrhoeae. 
Little is known about the Zn concentration at mucosal sites and how Zn is 
transported across the outer-membrane of Gram-negative bacteria.  It is thought that 
transport of the hydrophilic divalent Zn cation occurs passively via porins [86]. Our 
findings that TdfH, TdfJ and TonB contribute to Zn acquisition in N. gonorrhoeae as well 
as similar findings for the homologous proteins in N. meningitidis [225-226] indicate that 
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efficient Zn acquisition in Neisseria is TdT and TonB-mediated. ZnuD homologs with 50-
60% similarity have also been identified in other Gram-negative pathogenic bacteria 
residing primarily in mucosal epithelia [225]. This may indicate that Zn concentrations at 
mucosal sites are too low for passive Zn diffusion; as such an outer-membrane Zn 
transporter and metabolic energy may be required for active Zn uptake and growth in 
those environments [225].   
In sum, the data presented in this study indicates that TdfH and TdfJ contribute 
to Zn acquisition in N. gonorrhoeae and that TdfH is a calprotectin receptor. These 
findings are consistent with functions reported for TdfH and TdfJ homologues in N. 
meningitidis [225-226]. The data reported here, goes further to demonstrate that TdfH 
also assimilates Zn from CP and that direct utilization of CP enhances gonococcal NET 
survival. Our data presents a novel mechanism of gonococcal NET survival and 
highlights that many ways in which N. gonorrhoeae have successfully manipulated host-
pathogen interactions to its advantage. 
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CHAPTER 6: Summary and Perspectives 
 
 
The host strategy of limiting essential nutrients from invading pathogens, known 
as “nutritional immunity” is a prevalent theme in microbial defense. While traditionally 
characterized as the sequestration of iron from pathogens [257], roles for other 
transition metals such as zinc and manganese are now being examined [101, 117]. 
TonB-dependent transporters, as key mediators of nutrient acquisition in Gram-negative 
bacteria, are at the forefront of this fight for essential nutrients. Neisseria gonorrhoeae is 
particularity adept at overcoming host nutritional immunity strategies. Despite being 
unable to produce any siderophores to scavenge iron or iron chelates from the iron-
limited host environment, N. gonorrhoeae can express eight TonB-dependent 
transporters, five of which enable utilization of the following as iron sources: 
siderophores produced by other bacteria [36, 98], host iron binding proteins, transferrin 
[50] and lactoferrin [20] and the heme binding protein, hemoglobin [43]. Given the role 
of the transferrin and lactoferrin receptors in gonococcal pathogenesis [52], it is likely 
that the remaining uncharacterized TdTs also have important roles in the ability of N. 
gonorrhoeae to cause disease. These transporters also have the potential to be 
manipulated for the development of protective and anti-infective therapies. Accordingly, 
studies focusing on the function of the uncharacterized gonococcal TdTs, TdfG, TdfH 
and TdfJ, are well-justified.  
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In this study, we sought to characterize the function and regulation of TdfG, TdfH 
and TdfJ in Neisseria gonorrhoeae. To achieve this goal we first sought to determine 
the contribution of these receptors to gonococcal heme utilization.  TonB-independent 
heme utilization has been demonstrated in N. gonorrhoeae [19]; although it is not 
expected to be biologically relevant in vivo, where low heme levels would necessitate 
receptors that enable active and efficient heme utilization [19, 133, 209]. Given their 
similarity to heme receptors, TdfG, TdfH and TdfJ were naturally considered as 
candidates for gonococcal heme TdTs. However, neither TdfG nor TdfH were found to 
contribute to heme utilization in N. gonorrhoeae [238]. ZnuD, the meningococcal TdfJ 
homolog, binds heme and restores heme utilization in an E. coli hemA mutant but it is 
not required for heme utilization in N. meningitidis [126] indicating that alternative 
mechanisms of heme utilization outside of ZnuD may exist.  
In order to reconcile these reports we addressed the possibility that these 
receptors may be functionally redundant and generated double mutants incapable of 
expressing either TdfG and TdfJ or TdfH and TdfJ. When growth of these strains was 
evaluated, neither the TdTs nor TonB was found to contribute to growth. Additionally, 
TonB was not required for growth in a gonococcal heme auxotroph, dependent on 
exogenous heme uptake. Together these results indicate that TonB and by definition 
TdTs are not required for heme uptake in N. gonorrhoeae. Contrary to previous 
suppositions, we find that gonococcal heme utilization occurs independently of TonB 
and is thus passive even at low heme concentrations. These findings are in stark 
contrast to reports in other bacteria, which indicate that free heme utilization requires 
high affinity heme receptors for active TonB-dependent transport of heme [133]. It is not 
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clear why heme utilization in N. gonorrhoeae is TdT and TonB-independent. We 
postulate that the increased permeability of N. gonorrhoeae outer membranes to 
hydrophobic agents compared to other Gram-negative bacteria may allow for passive 
non-specific heme entry.  
We also addressed the possibility that the TdTs may not be required for free 
heme uptake but may facilitate utilization of a bacteria derived hemophore as a heme 
source analogous to N. gonorrhoeae xenosiderophore utilization [36, 98]. We identified 
a candidate hemophore and tested its ability to support gonococcal growth as a sole 
iron and/or heme source. We found that P. gingivalis hemophore-like protein, HusA, 
could not support gonococcal growth. While our results appear to suggest that N. 
gonorrhoeae does not encode a “xeno-hemophore” utilization system, further studies 
with different types of hemophores will be needed to confirm that conclusion since the 
bacterial hemophores described thus far are structurally and functionally diverse [253]. 
In the next objective of this study, the regulation of these TdTs was evaluated. All 
TdTs that facilitate the utilization of iron or iron-chelates are iron repressed. These TdTs 
are differentially regulated by iron; TdfG is iron-repressed, TdfH is not iron responsive 
and TdfJ is iron-induced, suggesting that some of these receptors may have functions 
outside of iron uptake. To better understand the context in which these receptors may 
be expressed and ascertain some information about their function, we assessed their 
expression in the absence of Fur, MisR and MpeR, which are all regulators of Neisseria 
virulence factors. We found that both Fur and MisR contribute to the iron regulation of 
TdfG. While Fur repressed TdfG expression in iron replete conditions, MisR activated 
TdfG expression in iron depleted conditions. Given the specificity of TdfG to Neisseria 
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gonorrhoeae and its regulation by MisR, which may be important for Neisseria 
adaptation to host cells [107], we predict that TdfG contributes to gonococcal 
pathogenesis by facilitating iron acquisition from a host specific source. TdfG is the 
largest gonococcal TdT; its larger size may indicate that it binds a protein ligand as 
opposed to a siderophore [226].  
We also found that TdfH and TdfJ are Zn-repressed and Zur regulated and that 
TdfH expression is distinct in different gonococcal strains. In N. gonorrhoeae strain 
FA1090, TdfH is not MisR regulated. However, overall levels of TdfH detected are 
reduced in strain FA19 compared to FA1090 and TdfH is MisR activated. TdfH 
expression is almost always detected in Neisseria meningitidis and Neisseria 
gonorrhoeae strains but is rarely detected in commensal Neisseria species despite the 
presence of tdfH in most Neisseria genomes [155, 226, 238] suggesting that TdfH 
expression is differentially regulated in pathogenic versus commensal Neisseria. Our 
studies did not find TdfH to be regulated by pathogenic Neisseria specific regulator 
MpeR in gonococcal strain FA1090, but this may be not be the case in different 
gonococcal strains. As such further studies to determine the direct or indirect 
contribution of any potential regulators should be conducted in multiple strains. 
Our findings emphasize the importance of characterizing gene products in 
various strains given the evidence of strain specific differences. FA19 and FA1090 are 
both routinely used lab strains but have reported genetic and phenotypic differences. In 
FA19, expression of the mtrCDE encoded efflux pump is inducible but is not in FA1090 
due to a deletion in MtrA, an AraC-like activator of the efflux pump [200]. Also, FA19 
encodes the gonococcal genetic island (GGI) while FA1090 does not. Components of a 
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GGI encoded Type IV secretion system confer a TonB and TdfF-independent 
mechanism of intracellular survival in FA19 [279]. Additionally, xenosiderophore 
utilization in FA19 is TonB and TdT-independent but is FetA dependent in FA1090 [98, 
227]. FA19 was originally isolated from a patient with uncomplicated infection and 
FA1090 isolated from the cervix from a patient with disseminated infection. 
Characterizing regulatory differences between strains will help to better understanding 
the variety of potential expression patterns of gene products during natural gonorrhea 
infections.           
In the final objective of this study, the contribution of TdfJ and TdfH to 
gonococcal Zn utilization was evaluated given their observed Zn/Zur repression. We 
found that TdfH, TdfJ and TonB were all important for growth in Zn depleted conditions 
indicating that Zn-utilization is TonB and TdT-dependent in N. gonorrhoeae. Zn passage 
across the outer-membrane of Gram-negative bacteria is thought to occur passively, 
potentially through porins [86]. The identification of two TdTs that facilitate Zn 
acquisition and are expressed in naturally occurring isolates of N. gonorrhoeae and N. 
meningitidis [225-226, 238] indicate that Neisseria must encounter low Zn 
concentrations in vivo and that efficient Zn utilization may in some conditions require 
TdTs. ZnuD homologs have been identified in pathogenic bacteria of the respiratory 
tract including Moraxella catarrhalis, Acinetobacter baumannii, and Bordetella pertussis 
[225] suggesting that active, TdT-mediated Zn acquisition may be a wide-spread theme 
in mucosal pathogens. Studies investigating the function of these homologs and their 
contribution to pathogenesis will be needed to better understand the importance of TdT-
mediated Zn acquisition.     
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This study also reports that TdfH is a calprotectin receptor. We demonstrate that 
TdfH is required for growth in the presence of CP, specifically binds CP and 
accumulates Zn from CP. These findings along with those reported for CbpA, the 
meningococcal TdfH homolog [226] identify a novel host protein that pathogenic 
Neisseria hijack to acquire the essential nutrient Zn.  
Many studies have focused on the antimicrobial effects of CP in vitro and in vivo 
[49, 58]. Several studies have found that Zn transport systems, specifically ABC 
transporters in Gram-negative bacteria enhance survival in the presence of CP [3, 57, 
100, 145]. This study along with that reported in N. meningitidis, represent the first 
reports of a surface receptor that binds to CP and is critical for CP resistance [226]. 
TdfH homologs are present in other bacteria, thus CP receptors may represent a new 
theme in microbial resistance to nutritional immunity. Apart from Neisseria spp. where 
TdfH homologs share over 90% identity, we have detected TdfH homologs in mostly 
opportunistic pathogens that normally colonize the human respiratory tract or mouth 
(Table 8). These homologs show 50-60% identity to TdfH and are often annotated as 
heme utilization proteins. One of such proteins, Hup of H. influenzae, shares 52% 
identity with TdfH and has been shown to contribute to heme utilization [166, 238], 
though our findings reported in Chapter 3 as well as previous reports [238] indicate that 
TdfH does not contribute to heme utilization in N. gonorrhoeae. As such, studies 
investigating the function of homologous TdTs will be needed to determine whether they 
are actually heme or CP receptors. Additional studies identifying epitopes involved in 
CP binding and Zn coordination will also help to better annotate homologs and further 
characterize this novel class of TdTs.  
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Calprotectin is highly expressed in neutrophils and is an active antimicrobial 
component of NETs [243]. Thus, we also evaluated the contribution of TdfH to N. 
gonorrhoeae NET survival and found that TdfH enhances gonococcal NET survival. 
Neutrophil recruitment is a hallmark of gonococcal infection. Despite the role of 
neutrophils in innate immunity, the ability to recover viable N. gonorrhoeae from 
neutrophil rich urethral exudates indicate that neutrophils are ineffective at clearing 
gonococcal infection [56]. Neisseria gonorrhoeae have a plethora of mechanisms to 
resist neutrophil mediated killing including resistance to oxidative stress, modulation of 
neutrophil granule release and efflux of antimicrobial components [56]. N. gonorrhoeae 
also induce NET formation independently of Opas and Pili, though these virulence 
factors can modulate NET formation [82]. 
Surprisingly, N. gonorrhoeae induced NETs do not stimulate ROS nor do they kill 
the bacteria [82] indicating that N. gonorrhoeae has NET resistance strategies. Recently 
N. gonorrhoeae was found to secrete a nuclease that facilitates escape from NETs 
[115]. Our findings that TdfH enhances gonococcal NET survival define a novel strategy 
of gonococcal NET resistance: direct utilization of CP as a Zn source, which neutralizes 
CP antimicrobial activity. In N. meningitidis, ZnuD was also found to be important for 
NET survival [129]. We did not evaluate the contribution of gonococcal ZnuD homolog, 
TdfJ to NET survival, though we suspect that it may also contribute to NET survival 
given its potential to mediate Zn acquisition. The evidence that TdTs involved in Zn  
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Table 8. TdfH homologs in opportunistic pathogens  
Organism Family Disease Accession 
number 
% 
Identity 
Acintobacillus ureae Pasteurellaceae Pneumonia, chronic 
respiratory disease 
WP_005621380.1 52 
Aggregatibacter 
actinomycetemcomitans 
Pasteurellaceae Periodontis, bacterial 
endocarditis 
WP_005578440 60 
Haemophilus 
haemolyticus 
Pasteurellaceae Bacteremia, pneumonia, 
endocarditis 
WP_005630735.1 51 
Haemophilus influenzae Pasteurellaceae Bacteremia, pneumonia, 
otitis media, epiglottitis, 
meningitis 
AAS75800.1 51 
Moraxella catarrhalis Moraxellaceae Sinusitis, otitis media, 
bronchitis, pneumonia 
WP_013107855.1 54 
Morococcus cerebrosus Neisseriaceae 
 
†Cerebellar abscess, 
Endopthalmitis,  
WP_039407935.1 65 
†Only two instances of disease by M. cerebrosus have been reported; see refs. [149, 
235]  
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acquisition contribute to NET survival indicate that nutritional immunity via CP-mediated 
Zn sequestration is a major component of NET-mediated killing.   
In all, the data presented in this study has yielded new information into the 
function and regulation of these TdTs in N. gonorrhoeae. Our initial characterization of 
TdfH as a CP receptor has laid the foundation for the description of a new class of TdTs 
that utilize CP as a nutrient source conferring a novel neutrophil/ NET resistance 
strategy. Understanding gonococcal mechanisms that subvert neutrophil defenses will 
help to expose pathways that can be manipulated for successful clearance of 
gonococcal infection. Furthermore, these TdTs may be good targets for novel and 
specific anti-gonorrhea therapies since they are surface-exposed, widely conserved in 
Neisseria gonorrhoeae strains and are not phase variable. Additionally, this study has 
revealed new insights into the conditions in which these TdTs may be expressed and 
strain specific differences in their regulation. These findings have opened new lines of 
investigation to further ascertain the functional mechanisms governing these TdTs as 
well as their potential for use as targets of protective and therapeutic strategies against 
gonococcal infection.            
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